腫瘍病理鑑別診断アトラス　腎癌

出版社： 文光堂
著者：
発行日： 2013-11-16
分野： 臨床医学：基礎  >  臨床病理学
ISBN： 9784830622397
シリーズ： 腫瘍病理鑑別診断アトラス
電子書籍版： 2013-11-16 （第1版第2刷）
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

16,500 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

16,500 円(税込)

購入する

商品紹介

腎実質上皮性腫瘍のみならず，非上皮性腫瘍，混合性腫瘍，小児腫瘍をも含めた，腎腫瘍の日常診断に即役立つアトラス．疾患毎の解説，鑑別診断，臨床との連携を含め詳述する．

目次

  • 腫瘍病理鑑別診断アトラス　腎癌

    ―目次―

    第１部　検鏡前の確認事項
    　?．腎腫瘍組織分類の現状
    　II．病理標本の取扱い方
    　III．腎腫瘍の免疫組織化学
    　IV．特殊検査法（分子生物学的手法）

    第２部　組織型と診断の実際
    　?．上皮性腫瘍
    　II．非上皮性および混合性腫瘍
    　III．小児腫瘍

    第３部　鑑別ポイント
    　?．淡明または好酸性細胞質をもつ腎腫瘍の鑑別
    　II．小型細胞からなる腫瘍
    　III．乳頭状，管状乳頭状構築を示す腫瘍の鑑別
    　IV．?胞状構築を示す腫瘍の鑑別
    　?．浸潤性増殖，紡錘形細胞からなる腫瘍の鑑別

    第４部　臨床との連携
    　?．腎癌の疫学
    　II．腎腫瘍性病変の放射線画像診断
    　III．腎腫瘍性病変の進行期と治療方針・予後
    　IV．家族性腫瘍症候群への対応
    　?．病理診断報告書の記載

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1部 検鏡前の確認事項

P.7 掲載の参考文献
1) Eble JN, Sauter G, Epstein JI et al (eds) : WHO Classification of Tumours. Pathology & Genetics. Tumours of the Urinary System and Male Genital Organs, IARC Press, Lyon, 2004
 
2) 日本泌尿器科学会, 日本病理学会, 日本医学放射線学会 (編) : 泌尿器科・病理・放射線科 腎癌取扱い規約, 第4版, 金原出版, 2011
 
3) Srigley JR, Delahunt B : Uncommon and recently described renal carcinomas. Mod Pathol 22 : S2-S23, 2009
PubMed
4) Nagashima Y, Kuroda N, Yao M : Transition of organizational category on renal cancer. Jpn J Clin Oncol 43 : 233-242, 2013
PubMed
5) Grawitz PA : le sogennnten Lipome der Niere. Virchows Arch (Pathol Anat) 93 : 39-63, 1883
 
6) Sudeck P : Zwei Faelle von Adenosarcom der Niere. Virchows Arch (Pathol Anat) 133 : 558-562, 1893
 
7) Farrow GM, Harrison EG Jr, Uts DC : Sarcomas and sarcomatoid and mixed malignant tumors of the kidney in adult. Part III. Cancer 22 : 556-563, 1968
 
8) Bennington JI, Beckwith JB : Tumors of the Kidney, Renal Pelvis and Ureter. Atlas of Tumor Pathology, Ser 2, Fasc 12, AFIP, Washington, DC, 1975
 
9) Klein MJ, Vakensi QJ : Proximal tubular adenomas of kidney with so-called oncocytic features : a clinicopathologic study on 13 cases of a rarely reported neoplasms. Cancer 38 : 906-914, 1976
 
10) Mostofi FK, Sesterhenn IA, Sobin LH : International Histological Classification of Tumours, No 25, Histological Typing of Kidney Tumours, WHO, Geneva, 1981
 
11) 日本泌尿器科学会, 日本病理学会, 日本医学放射線学会 (編) : 泌尿器科・病理・放射線科 腎癌取扱い規約, 第1版, 金原出版, 1983
 
12) 日本泌尿器科学会, 日本病理学会, 日本医学放射線学会 (編) : 泌尿器科・病理・放射線科 腎癌取扱い規約, 第2版, 金原出版, 1992
 
13) Mancilla-Jimenez R, Stanley RJ, Blath RA : Papillary renal cell carcinoma : a clinical, radiologic, and pathologic study of 34 cases. Cancer 38 : 2469-2480, 1976
PubMed
14) Presti JC Jr, Rao PH, Chen Q et al : Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Cancer Res 51 : 1544-1552, 1991
PubMed
15) Fleming S, Lewi HJ : Collecting duct carcinoma of the kidney. Histopathology 10 : 1131-1141, 1986
PubMed
16) Aizawa S, Kikuchi Y, Suzuki M et al : Renal cell carcinoma of lower nephron origin. Acta Pathol Jpn 37 : 567-574, 1987
PubMed
17) Thoenes W, Storkel S, Rumpelt HJ : Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 181 : 125-143, 1986
PubMed
18) Kovacs G, Akhtar M, Beckwith BJ et al : The Heidelberg classification of renal cell tumours. J Pathol 183 : 131-133, 1997
PubMed
19) Mostofi FK, Davis DJ Jr (eds) : World Health Organization International Classification of Tumours. Histological Typing of Kidney Tumours, 2nd ed. Springer, Berlin, Heidelberg, 1998
 
20) 日本泌尿器科学会, 日本病理学会, 日本医学放射線学会 (編) : 泌尿器科・病理・放射線科 腎癌取扱い規約, 第3版, 金原出版, 1999
 
21) Latif F, Tory K, Gnarra J et al : Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260 : 1317-1320, 1993
PubMed
22) Nagashima Y, Kobayashi N, Kagawa E et al : Chapter 2. Pathology and molecular biology of renal neoplasms : recent advances and impacts on pathological classification. in Nakamura M, Kakudo K (eds) : "Molecular Mechanism and Morphology in Cancer", Bentham Science Publishers Ltd, Oak Park, 2009, pp12-38
 
23) Shuin T, Kondo K, Torigoe S et al : Frequent somatic mutation and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 54 : 2852-2855, 1994
 
24) McLennan GT, Chen L : Neoplasms of the kidney. in Bostowick DG, Chen L (eds) : "Urologic Surgical Pathology", 2nd ed, Mosby Elsevier, Philadelphia, 2008, pp77-172
 
25) Tickoo SK, de Peralta-Venturina MN, Harik LR et al : Spectrum of epithelial neoplasms in end-stage renal disease : an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 30 : 141-153, 2006
PubMed
26) Pavlovich CP, Walther MM, Eyler RA et al : Renal tumors in the Birt-Hogg-Dube syndrome. Am J Surg Pathol 26 : 1542-1552, 2002
PubMed
27) Waldert M, Klatte T, Haitel A et al : Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes. Eur Urol 57 : 661-665, 2010
PubMed
28) Zhou M, Yang XJ, Lopez JI et al : Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma : implications for pathologic classification. Am J Surg Pathol 33 : 1840-1849, 2009
PubMed
29) Inoue T, Matsuura K, Yoshimoto T et al : Genomic profiling of renal cell carcinoma in patients with end-stage renal disease. Cancer Sci 103 : 569-576, 2012
PubMed
30) Ohe C, Kuroda N, Hes O et al : A renal epithelioid angiomyolipoma/perivascular epithelioid cell tumor with TFE3 gene break visualized by FISH. Med Mol Morphol 45 : 234-237, 2012
PubMed
31) Kuroda N, Toi M, Hiroi M et al : Review of metanephric adenoma of the kidney with focus on clinical and pathobiological aspects. Histol Histopathol 18 : 253-257, 2003
 
32) 日本病理学会小児腫瘍組織分類委員会 (編) : 小児腫瘍組織カラーアトラス, 第4巻 小児腎腫瘍, 金原出版, 2008
 
33) Dome JS, Coppes MJ : Recent advances in Wilms tumor genetics. Curr Opin Pediatr 14 : 5-11, 2002
PubMed
34) Miller-Hodges E, Hohenstein P : WT1 in disease : shifting the epithelial-mesenchymal balance. J Pathol 226 : 229-240, 2012
PubMed
35) Kato I, Inayama Y, Yamanaka S et al : Epithelioid angiomyolipoma of the kidney. Pathol Int 59 : 38-43, 2009
PubMed
36) Siroky BJ, Czyzyk-Krzeska MF, Bissler JJ : Renal involvement in tuberous sclerosis complex and von Hippel-Lindau disease : shared disease mechanisms? Nat Clin Pract Nephrol 5 : 143-156, 2009
PubMed
37) Kenerson H, Folpe AL, Takayama TK et al : Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms. Hum Pathol 38 : 1361-1371, 2007
PubMed
38) Orlova KA, Crino PB : The tuberous sclerosis complex. Ann N Y Acad Sci 1184 : 87-105, 2010
PubMed
39) Shitara K, Yatabe Y, Mizota A et al : Dramatic tumor response to everolimus for malignant epithelioid angiomyolipoma. Jpn J Clin Oncol 41 : 814-816, 2011
PubMed
40) Kuroda N, Gotoda H, Ohe C et al : Review of juxtaglomerular cell tumor with focus on pathobiological aspect. Diagn Pathol 6 : 80, 2011
PubMed
41) Sakata R, Shimoyamada H, Yanagisawa M et al : Nonfunctioning juxtaglomerular cell tumor. Case Rep Pathol 2013, 973865, 2013
PubMed
42) Zhou M, Kort E, Hoekstra P et al : Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney are the same disease entity : molecular and histologic evidence. Am J Surg Pathol 33 : 72-80, 2009
PubMed
43) Mohanty SK, Parwani AV : Mixed epithelial and stromal tumors of the kidney : an overview. Arch Pathol Lab Med 133 : 1483-1486, 2009
PubMed
44) Jung SJ, Shen SS, Tran T et al : Mixed epithelial and stromal tumor of kidney with malignant transformation : report of two cases and review of literature. Hum Pathol 39 : 463-468, 2008
PubMed
45) Kawahara T, Sekiguchi Z, Makiyama K et al : Primary synovial sarcoma of the kidney. Case Rep Oncol 2 : 189-193, 2009
PubMed
46) Klimstra DS : Pathology reporting of neuroendocrine tumors : essential elements for accurate diagnosis, classification, and staging. Semin Oncol 40 : 23-36, 2013
PubMed
47) Li L, Parwani AV : Xanthogranulomatous pyelonephritis. Arch Pathol Lab Med 135 : 671-674, 2011
PubMed
P.16 掲載の参考文献
1) 日本泌尿器科学会, 日本病理学会, 日本医学放射線学会 (編) : 泌尿器科・病理・放射線科 腎癌取扱い規約, 第4版, 金原出版, 2011
 
2) 長嶋洋治, 田口多美代, 古林直人他 : 腎臓 (手術). 外科病理マニュアル, 病理と臨床 26 (臨増) : 277-282, 2008
 
3) Lester SC : Genitourinary specimens. in Lester SC (ed) : "Manual of Surgical Pathology", 3rd ed, Elsevier Saunders, Philadelphia, 2010, pp384-395
 
4) Qualman SJ, Bowen J, Amin MB et al : Protocol for the examination of specimens from patients with Wilms tumor (nephroblastoma) or other renal tumors of childhood. Arch Pathol Lab Med 127 : 1280-1289, 2003
PubMed
5) UICC International Union Against Cancer : TNM Classification of Malignant Tumours, 7th ed, Wiley-Blackwell, Oxford, 2009
 
6) Meng MV, Koppie TM, Duh QY et al : Novel method of assessing surgical margin status in laparoscopic specimens. Urology 58 : 677-681, 2001
PubMed
7) Meng MV, Koppie TM, Stoller ML : Pathologic sampling of laparoscopically morcellated kidneys : a mathematical model. J Endourol 17 : 229-233, 2003
PubMed
8) Meng MV, Miller TR, Cha I et al : Cytology of morcellated renal specimens : significance in diagnosis and dissemination. J Urol 169 : 45-48, 2003
PubMed
9) Beckwith JB : National Wilms Tumor Study : an update for pathologists. Pediatr Dev Pathol 1 : 79-84, 1998
PubMed
P.26 掲載の参考文献
1) Shen SS, Truong LD, Scarpelli M et al : Role of immunohistochemistry in diagnosing renal neoplasms. When is it really useful? Arch Pathol Lab Med 136 : 410-417, 2012
PubMed
2) Pan CC, Chen PC, Ho DM : The diagnostic utility of MOC31, BerEP4, RCC Marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma : an immunohistochemical analysis of 328 cases. Histopathology 45 : 452-459, 2004
PubMed
3) Truong LD, Shen SS : Immunohistochemical diagnosis of renal neoplasms. Arch Pathol Lab Med 135 : 92-109, 2011
PubMed
4) Gupta R, Balzer B, Picken M et al : Diagnostic implications of transcription factor Pax2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms. Am J Surg Pathol 33 : 241-247, 2009
PubMed
5) Paner GP, Srigley JR, Radhakrishnan A et al : Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney. Significant immunophenotypic overlap warrants diagnostic caution. Am J Surg Pathol 30 : 13-19, 2006
PubMed
6) Szponar A, Beothe T, Kovacs G et al : How useful is α-methylacyl-CoA racemase (AMACR) immunohistochemistry in the differential diagnosis of the kidney cancers? Histopathology 56 : 263-265, 2010
 
7) Shen SS, Kirshna B, Chirala R et al : Kidney-specific cadherin, a specific marker for the distal portion of the nephron and related renal neoplasms. Mod Pathol 18 : 933-940, 2005
 
8) Yusenko MV, Kovacs G : Identifying CD82 (KAI1) as a marker for human chromophobe renal cell carcinoma. Histopathology 55 : 687-695, 2009
PubMed
9) Ohe C, Kuroda N, Takasu K et al : Utility of immunohistochemical analysis of KAI1, epithelial specific antigen and epithelial related antigen for distinction of chromophobe renal cell carcinoma, eosinophilic variant from renal oncocytoma. Med Mol Morphol 45 : 98-104, 2012
PubMed
10) Argani P, Hicks J, De Marzo AM et al : Xp11 translocation renal cell carcinoma (RCC) : extended immunohistochemical profile emphasizing novel RCC markers. Am J Surg Pathol 34 : 1295-1303, 2010
PubMed
11) Argani P, Lal P, Hutchinson B et al : Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions. A sensitive and specific immunohistochemical assay. Am J Surg Pathol 27 : 750-761, 2003
PubMed
12) 日本泌尿器科学会, 日本病理学会, 日本医学放射線学会 (編) : 泌尿器科・病理・放射線科 腎癌取扱い規約, 第4版, 金原出版, 2011
 
13) Martignoni G, Pea M, Gobbo S et al : Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas. Mod Pathol 22 : 1016-1022, 2009
PubMed
14) Martignoni G, Bonetti F, Chilosi M et al : Cathepsin K expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney. Mod Pathol 25 : 100-111, 2012
PubMed
15) Skinnider BF, Amin MB : An immunohistochemical approach to the differential diagnosis of renal tumors. Semin Diagn Pathol 22 : 51-68, 2005
 
16) Gobbo S, Elbe JN, Grignon DJ et al : Clear cell papillary renal cell carcinoma. A distinct histopathologic and molecular genetic entity. Am J Surg Pathol 32 : 1239-1245, 2008
 
17) Went P, Dirnhofer S, Salvisberg T et al : Expression of epithelial cell adhesion molecule (EpCam) in renal epithelial tumors. Am J Surg Pathol 29 : 83-88, 2005
PubMed
18) Rao Q, Liu B, Cheng L et al : Renal cell carcinoma with t (6 ; 11) (p21 ; q12) : a clinicopathologic study emphasizing unusual morphology, novel alpha-TFEB gene fusion point, immunobiomarkers, and ultrastructural features, as well as detection of the gene fusion by fluorescence in situ hybridization. Am J Surg Pathol 36 : 1327-1338, 2012
 
19) Eble JN, Sauter G, Epstein JI et al (eds) : WHO Classification of Tumours. Pathology & Genetics. Tumours of the Urinary System and Male Genital Organs, IARC Press, Lyon, 2004, pp33-34
 
20) Albadine R, Schultz L, Illei P et al : PAX8+/p63-immunostaining pattern in renal collecting duct carcinoma (CDC) : a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract. Am J Surg Pathol 34 : 965-969, 2010
PubMed
21) Amin MB, Mckenney JK, Tickoo ST et al (eds) : Diagnostic Pathology Genitourinary, Amirsys. Manitoba, 2010
 
22) 都築豊徳, 前田永子, 岩崎博文 : 腎腫瘍針生検の病理. 病理と臨床 30 : 973-977, 2012
Medical*Online
23) Al-Ahmadie HA, Alden D, Fine SW et al : Role of immunohistochemistry in the evaluation of needle core biopsies in adult renal cortical tumors : an ex vivo study. Am J Surg Pathol 35 : 949-961, 2011
 
24) Kuroda N, Tanaka A, Yamaguchi T et al : Chromophobe renal cell carcinoma, oncocytic variant : a proposal of a new variant giving a critical diagnostic pitfall in diagnosing renal oncocytic tumors. Med Mol Morphol 46 : 49-55, 2013
PubMed
P.35 掲載の参考文献
1) Schreck RR, Warburton D, Miller OJ et al : Chromosome structure as revealed by a combined chemical and immunochemical procedure. Proc Natl Acad Sci 70 : 804-807, 1973
PubMed
2) Schrock E, Manoir S, Veldman T et al : Multicolor spectral karyotyping of human chromosomes. Science 273 : 494-497, 1996
PubMed
3) Kallioniemi A, Kallioniemi OP, Sudar D et al : Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258 : 818-821, 1992
PubMed
4) Pinkel D, Segraves R, Sudar D et al : High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20 : 207-211, 1998
PubMed
5) Pollack JR, Perou CM, Alizadeh AA et al : Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 23 : 41-46, 1999
PubMed
6) Brennan C, Zhang Y, Leo C et al : High-resolution global profiling of genomic alterations with long oligonucleotide microarray. Cancer Res 64 : 4744-4748, 2004
PubMed
7) Zhao X, Li C, Paez JG et al : An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res 64 : 3060-3071, 2004
 
8) Gerlinger M, Rowan AJ, Horswell S et al : Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366 : 883-892, 2012
PubMed
9) Wilhelm M, Veltman JA, Olshen AB et al : Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer. Cancer Res 62 : 957-960, 2002
PubMed
10) Hagenkord JM, Gatalica Z, Jonasch E et al : Clinical genomics of renal epithelial tumors. Cancer Genet 204 : 285-297, 2011
PubMed
11) Tickoo SK, dePeralta-Venturina MN, Harik LR et al : Spectrum of epithelial neoplasms in end-stage renal disease : an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 30 : 141-153, 2006
PubMed
12) Cheuk W, Lo ES, Chan AK et al : Atypical epithelial proliferations in acquired renal cystic disease harbor cytogenetic aberrations. Hum Pathol 33 : 761-765, 2002
PubMed
13) Inoue T, Matsuura K, Yoshimoto T et al : Genomic profiling of renal cell carcinoma in patients with end-stage renal disease. Cancer Sci 103 : 569-576, 2012
PubMed
14) Yoshimoto T, Matsuura K, Karnan S et al : High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma. J Pathol 213 : 392-401, 2007
PubMed

第2部 組織型と診断の実際

P.45 掲載の参考文献
1) 日本泌尿器科学会, 日本病理学会, 日本医学放射線学会 (編) : 泌尿器科・病理・放射線科 腎癌取扱い規約, 第4版, 金原出版, 2011
 
2) Eble JN, Sauter G, Epstein JI et al (eds) : WHO Classification of Tumors. Pathology & Genetics. Tumours of the Urinary System and Male Genital Organs, IARC Press, Lyon, 2005
 
3) Murphy WM Grignon DJ, Perlman EJ (eds) : AFIP Atlas of Tumor Pathology, Fourth series, Fascicle 1 : Tumor of the Kidney, Bladder, and Related Urinary Structures. AFIP, Washington DC, 2004
 
4) Staehler M, Rohrmann K, Haseke N et al : Targeted agents for the treatment of advanced renal cell carcinoma. Curr Drug Targets 6 : 835-846, 2005
PubMed
5) Fuhrman SA, Lasky LC, Limas C : Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6 : 655-663, 1982
PubMed
6) Al-Ahmadie HA, Alden D, Fine SW et al : Role of immunohistochemistry in the evaluation of needle core biopsies in adult renal cortical tumors : an ex vivo study. Am J Surg Pathol 35 : 949-961, 2011
 
7) Negrier S, Escudier B, Lasset C et al : Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Francais d'Immunotherapie. N Engl J Med 338 : 1272-1278, 1998
 
8) Rini BI, Atkins MB : Resistance to targeted therapy in renal-cell carcinoma. Lancet Oncol 10 : 992-1000, 2009
PubMed
P.49 掲載の参考文献
1) 日本泌尿器科学会, 日本病理学会, 日本医学放射線学会 (編) : 泌尿器科・病理・放射線科 腎癌取扱い規約, 第4版, 金原出版, 2011
 
2) Eble JN, Sauter G, Epstein JI et al (eds) : WHO Classification of Tumours. Pathology & Genetics. Tumours of the Urinary System and Male Genital Organs, IARC Press, Lyon, 2005
 
3) Murphy WM, Grignon DJ, Perlman EJ (eds) : AFIP Atlas of Tumor Pathology, Fourth series, Fascicle 1 : Tumor of the Kidney, Bladder, and Related Urinary Structures, ARP, Washington DC, 2004
 
4) Kuroda N, Ohe C, Mikami S et al : Multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 27 : 969-974, 2012
PubMed
5) Li G, Bilal I, Gentil-Perret A et al : CA9 as a molecular marker for differential diagnosis of cystic renal tumors. Urol Oncol 30 : 463-468, 2012
PubMed
6) Williamson SR, Halat S, Eble JN et al : Multilocular cystic renal cell carcinoma : similarities and differences in immunoprofile compared with clear cell renal cell carcinoma. Am J Surg Pathol 36 : 1425-1433, 2012
PubMed
7) Eble JN, Bonsib SM : Extensively cystic renal neoplasms : cystic nephroma, cystic partially differentiated nephroblastoma, multilocular cystic renal cell carcinoma, and cystic hamartoma of renal pelvis. Semin Diagn Pathol 15 : 2-20, 1998
PubMed
8) Mikami S, Oya M, Mukai M : Angiomyolipoma with epithelial cysts of the kidney in a man. Pathol Int 58 : 664-667, 2008
 
P.55 掲載の参考文献
1) Delahunt B, Eble JN : Papillary renal cell carcinoma. in Eble JN, Sauter G, Epstein JI et al (eds) : "WHO Classification of Tumours. Pathology & Genetics. Tumours of the Urinary System and Male Genital Organs", IARC Press, Lyon, 2004, pp27-29
 
2) Zbar B, Tory K, Merino M et al : Hereditary papillary renal cell carcinoma. J Urol 151 : 561-566, 1994
PubMed
3) Kiuru M, Launonen V, Hietala M et al : Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology. Am J Pathol 159 : 825-829, 2001
PubMed
4) Launonen V, Vierimaa O, Kiuru M et al : Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci USA 98 : 3387-3392, 2001
PubMed
5) MacLennan GT, Cheng L : Neoplasms of the kidney. in Bostwick DG, Cheng L (eds) : "Urologic Surgical Pathology", 2nd ed, Elsevier, Philadelphia, 2008, pp78-171
 
6) Capitanio U, Cloutier V, Zini L et al : A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma : a population-based study. BJU Int 103 : 1496-1500, 2009
PubMed
7) Steffens S, Janssen M, Roos FC et al : Incidence and longterm prognosis of papillary compared to clear cell renal cell carcinoma-a multicentre study. Eur J Cancer 48 : 2347-2352, 2012
PubMed
8) Sika-Paotonu D, Bethwaite PB, McCredie MR et al : Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. Am J Surg Pathol 30 : 1091-1096, 2006
PubMed
9) Klatte T, Pantuck AJ, Said JW et al : Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma. Clin Cancer Res 15 : 1162-1169, 2009
PubMed
10) Delahunt B, Eble JN : Papillary renal cell carcinoma : a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 10 : 537-544, 1997
PubMed
11) Amin MB, Corless CL, Renshaw AA et al : Papillary (chromophil) renal cell carcinoma : histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am J Surg Pathol 21 : 621-635, 1997
PubMed
12) Murphy WM, Grignon DJ, Perlman EJ : Renal cell carcinoma, papillary type. in Murphy WM, Grignon DJ, Perlman EJ (eds) : "AFIP Atlas of Tumor Pathology, Fourth series, Fascicle 1 : Tumor of the Kidney, Bladder, and Related Urinary Structures", ARP, Washington, DC, 2004, pp123-130
 
13) Schmidt L, Duh FM, Chen F et al : Germline and somatic mutations in the tyrosine kinase domain of the MET protooncogene in papillary renal carcinomas. Nat Genet 16 : 68-73, 1997
PubMed
14) Lubensky IA, Schmidt L, Zhuang Z et al : Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype. Am J Pathol 155 : 517-526, 1999
 
15) Tomlinson IP, Alam NA, Rowan AJ et al : Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30 : 406-410, 2002
PubMed
16) Hes O, Brunelli M, Michal M et al : Oncocytic papillary renal cell carcinoma : a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases. Ann Diagn Pathol 10 : 133-139, 2006
PubMed
17) Mai KT, Kohler DM, Roustan Delatour NL et al : Cytohistopathologic hybrid renal cell carcinoma with papillary and clear cell features. Pathol Res Pract 202 : 863-868, 2006
PubMed
18) Mai KT, Faraji H, Desantis D et al : Renal cell carcinoma with mixed features of papillary and clear cell cytomorphology : a fluorescent in situ hybridization study. Virchows Arch 456 : 77-84, 2010
PubMed
19) Bishop JA, Sharma R, Illei PB : Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. Hum Pathol 41 : 20-25, 2010
PubMed
20) Kanomata N, Sato Y, Miyaji Y et al : Vasohibin-1 is a new predictor of disease-free survival in operated renal cell carcinoma patients. J Clin Pathol 66 : 613-619, 2013
PubMed
21) Delahunt B, Eble JN, McCredie MR et al : Morphologic typing of papillary renal cell carcinoma : comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 32 : 590-595, 2001
PubMed
22) Kuroda N, Toi M, Hiroi M et al : Review of papillary renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 18 : 487-494, 2003
PubMed
23) Choueiri TK, Vaishampayan U, Rosenberg JE et al : Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma. J Clin Oncol 31 : 181-186, 2013
PubMed
P.62 掲載の参考文献
1) 日本泌尿器科学会, 日本病理学会, 日本医学放射線学会 (編) : 泌尿器科・病理・放射線科 腎癌取扱い規約, 第4版, 金原出版, 2011
 
2) Storkel S, Martignoni G, van den Berg E : Chromophobe renal cell carcinoma. in Eble JN, Sauter G, Epstein JI et al (eds) : "WHO Classification of Tumours. Pathology & Genetics. Tumours of the Urinary System and Male Genital Organs", IARC Press, Lyon, 2004, pp30-32
 
3) Murphy WM, Grignon DJ, Perlman EJ : Renal cell carcinoma, chromophobe cell type. in Murphy WM Grignon DJ, Perlman EJ (eds) : "AFIP Atlas of Tumor Pathology, Fourth series, Fascicle 1 : Tumors of the Kidney, Bladder, and Related Urinary Structures", ARP, Washington DC, 2004, pp130-136
 
4) Thoenes W, Storkel S, Rumpelt HJ : Human chromophobe cell renal carcinoma. Virchows Arch 48 : 207-217, 1985
PubMed
5) Storkel S, Steart PV, Drenckhann D et al : Human chromophobe cell renal carcinoma : probable relation to intercalated cells of collecting duct. Virchows Arch 56 : 237-245, 1989
 
6) Iqbal MA, Akhtar M, Ali MA : Cytogenetic findings of renal cell carcinoma. Hum Pathol 27 : 949-954, 1996
 
7) 黒田直人, 長嶋洋治 : 嫌色素性腎細胞癌とオンコサイトーマ. 病理と臨床 28 : 1043-1047, 2010
Medical*Online
8) Nagshima Y : Chromophobe renal cell carcinoma : Clinical, pathological and molecular biological aspects. Pathol Int 50 : 872-878, 2000
 
9) Kuroda N, Toi M, Hiroi M et al : Review of chromophobe renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 18 : 165-171, 2003
PubMed
10) 陣崎雅弘, 秋田大宇, 栗林幸夫他 : 腎腫瘍の画像診断. 病理と臨床 28 : 1029-1036, 2010
Medical*Online
11) Amin MB, Paner GP, Alvarado-Cabrero I et al : Chromophobe renal cell carcinoma : Histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases. Am J Surg Pathol 32 : 1822-1834, 2008
PubMed
12) Delahunt B, Sika-Paotonu D, Bethwaite PB et al : Fuhrman grading is not appropriate for chromophobe renal cell carcinoma. Am J Surg Pathol 31 : 957-960, 2007
 
13) Paner GP, Amin MB, Alvarado-Cabrero I et al : A novel tumor grading schema for chromophobe renal cell carcinoma. Prognostic utility and comparison with Fuhrman nuclear grade. Am J Surg Pathol 34 : 1233-1240, 2010
 
14) Cheville JC, Lohse CM, Sukov WR et al : Chromophobe renal cell carcinoma : The impact of tumor grade on outcome. Am J Surg Pathol 36 : 851-856, 2012
PubMed
15) Vera-Badillo FE, Conde E, Duran I : Chromophobe renal cell carcinoma : A review of an uncommon entity. Int J Urol 21 : 1-7, 2012
 
16) Abrahams NA, MacLennan GT, Khoury JD et al : Chromophobe renal cell carcinoma : a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray. Histopathology 45 : 593-602, 2004
PubMed
17) Yusenko MV : Molecular pathology of chromophobe renal cell carcinoma : A review. Int J Urol 17 : 592-600, 2010
PubMed
18) Kuroda N, Toi M, Hiroi M et al : Review of renal oncocytoma with focus on clinical and pathobiological aspects. Histol Histopathol 18 : 935-942, 2003
PubMed
19) Kuroda N, Mikami S, Pan CC et al : Review of renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions with focus on pathobiological aspect. Histol Histopathol 27 : 133-140, 2012
PubMed
20) Pavlovich CP, Walther MM, Eyler RA et al : Renal tumors in the Birt-Hogg-Dube syndrome. Am J Surg Pathol 26 : 1542-1552, 2002
PubMed
21) Tickoo SK, Reuter VE, Amin MB et al : Renal oncocytosis. A morphologic study of fourteen cases. Am J Surg Pathol 23 : 1094-1101, 1998
 
22) Petersson F, Gatalica Z, Grossmann P et al : Sporadic hybrid oncocytic/chromophobe tumor of the kidney : a clinicopathologic, histomophologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases. Virchows Arch 456 : 355-365, 2010
 
23) Nouh MA, Kuroda N, Yamashita M et al : Renal cell carcinoma in patients with end-stage renal disease : relationship between histological type and duration of dialysis. BJU Int 105 : 620-627, 2009
PubMed
24) Kuroda N, Ohe C, Mikami S et al : Review of acquired cystic disease-associated renal cell carcinoma with focus on pathobiological aspects. Histol Histopathol 26 : 1215-1218, 2011
PubMed
25) Kuroda N, Pan CC : Renal angiomyolipoma : clinical and histological spectrum. Urological Science 22 : 40-42, 2011
 
P.67 掲載の参考文献
1) Srigley JR, Eble JN : Collecting duct carcinoma of kidney. Semin Diagn Pathol 15 : 54-67, 1998
PubMed
2) Aizawa S, Kikuchi Y, Suzuki M et al : Renal cell carcinoma of lower nephron origin. Acta Pathol Jpn 37 : 567-574, 1987
PubMed
3) Fleming S, Lewi HJ : Collecting duct carcinoma of the kidney. Histopathology 10 : 1131-1141, 1986
PubMed
4) Srigley JR, Delahunt B : Uncommon and recently described renal carcinomas. Mod Pathol 22 : S2-S23, 2009
PubMed
5) Tokuda N, Naito S, Matsuzaki O et al : Collecting duct (Bellini duct) renal cell carcinoma : a nation-wide survey in Japan. J Urol 176 : 43-46, 2006
 
6) Bostowick DG, Cheng L (eds) : Urologic Surgical Pathology, 2nd ed, Elsevier, Amsterdam, 2008
 
7) Eble JN, Sauter G, Epstein JI et al (eds) : WHO Classification of Tumours. Pathology & Genetics. Tumours of the Urinary System and Male Genital Organs, IARC Press, Lyon, 2004
 
8) Pinto JA, Menolascino F, Daboin I et al : Ductal cell carcinoma of the kidney with extensive signet ring cell mucosecreting areas. A case report with immunohistochemical analysis. Pathol Res Pract 197 : 827-832, 2001
 
9) Kobayashi N, Matsuzaki O, Shirai S et al : Collecting duct carcinoma of the kidney : an immunohistochemical evaluation of the use of antibodies for differential diagnosis. Hum Pathol 39 : 1350-1359, 2008
PubMed
10) Gupta R, Billis A, Shah RB et al : Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma : clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma with a focus on their interrelationship. Am J Surg Pathol 36 : 1265-1278, 2012
PubMed
11) Calvalho JC, Thomas DG, McHugh JB et al : p63, CK7, PAX8 and INI1 : an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high grade tumors of the renal collecting system. Histopathology 60 : 597-608, 2012
 
12) Amin MB, McKenny JK, Tickoo SK et al (eds) : Diagnostic Pathology Genitourinary, Amirsys, Canada, 2010
 
13) MacLennan GT, Farrow GM, Bostwick DG : Low-grade collecting duct carcinoma of the kidney : report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin. Urology 50 : 679-684, 1997
PubMed
14) Murphy WM, Grignon DJ, Perlman EJ (eds) : AFIP Atlas of Tumor Pathology, Fourth series, Fascicle 1, Tumors of the Kidney, Bladder, and Related Urinary Structures, American Registry of Pathology, Washinton DC, 2004
 
P.71 掲載の参考文献
1) Davis CJ Jr, Mostofi FK, Sesterhenn IA : Renal medullary carcinoma. The seventh sickle cell nephropathy. Am J Surg Pathol 19 : 1-11, 1995
 
2) Adsay NV, deRoux SJ, Sakr W et al : Cancer as a marker of genetic medical disease : an unusual case of medullary carcinoma of the kidney. Am J Surg Pathol 22 : 260-264, 1998
PubMed
3) Dimashkieh H, Choe J, Mutema G : Renal medullary carcinoma : a report of 2 cases and review of the literature. Arch Pathol Lab Med 127 : e135-e138, 2003
PubMed
4) Yang XJ, Sugimura J, Tretiakova MS et al : Gene expression profiling of renal medullary carcinoma : potential clinical relevance. Cancer 100 : 976-985, 2004
PubMed
5) Gupta R, Billis A, Shah RB et al : Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma : clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma with a focus on their interrelationship. Am J Surg Pathol 36 : 1265-1278, 2012
PubMed
6) Simpson L, He X, Pins M et al : Renal medullary carcinoma and ABL gene amplification. J Urol 173 : 1883-1888, 2005
PubMed
7) Kalyanpur A, Schwartz DS, Fields JM et al : Renal medulla carcinoma in a white adolescent. AJR Am J Roentgenol 169 : 1037-1038, 1997
 
8) Watanabe IC, Billis A, Guimaraes MS et al : Renal medullary carcinoma : report of seven cases from Brazil. Mod Pathol 20 : 914-920, 2007
PubMed
9) Mathur SC, Schwar tz AM : Pathologic quiz case : a 33-year-old man with an abdominal mass. Arch Pathol Lab Med 124 : 1561-1563, 2000
 
10) Selby DM, Simon C, Foley JP et al : Renal medullary carcinoma : can early diagnosis lead to long-term survival? J Urol 163 : 1238, 2000
 
11) Pirich LM, Chou P, Walterhouse DO : Prolonged survival of a patient with sickle cell trait and metastatic renal medullary carcinoma. J Pediatr Hematol Oncol 21 : 67-69, 1999
PubMed
12) Stahlschmidt J, Cullinane C, Roberts P et al : Renal medullary carcinoma : prolonged remission with chemotherapy, immunohistochemical characterisation and evidence of bcr/abl rearrangement. Med Pediatr Oncol 33 : 551-557, 1999
PubMed
13) Khan A, Thomas N, Costello B et al : Renal medullary carcinoma : sonographic, computed tomography, magnetic resonance and angiographic findings. Eur J Radiol 35 : 1-7, 2000
PubMed
14) Rodriguez-Jurado R, Gonzalez-Crussi F : Renal medullary carcinoma. Immunohistochemical and ultrastructural observations. J Urol Pathol 4 : 191-203, 1996
 
15) Sigauke E, Rakheja D, Maddox DL et al : Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue : an immunohistochemical study with implications for diagnosis. Mod Pathol 19 : 717-725, 2006
 
16) Bonham VL, Dover GJ, Brody LC : Screening student athletes for sickle cell trait-a social and clinical experiment. N Engl J Med 363 : 997-999, 2010
PubMed
P.76 掲載の参考文献
1) Clark J, Lu YJ, Sidhar SK et al : Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene 15 : 2233-2339, 1997
 
2) Argani P, Antonescu CR, Illei PB et al : Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma : a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 159 : 179-192, 2001
PubMed
3) Argani P, Antonescu CR, Couturier J et al : PRCC-TFE3 renal carcinomas : morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t (X ; 1) (p11.2 ; q21). Am J Surg Pathol 26 : 1553-1566, 2002
 
4) Argani P, Lui MY, Couturier J et al : A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t (X ; 17) (p11.2 ; q23). Oncogene 22 : 5374-5378, 2003
 
5) Bruder E, Passera O, Harms D et al : Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am J Surg Pathol 28 : 1117-1132, 2004
 
6) Argani P, Olgac S, Tickoo SK et al : Xp11 translocation renal cell carcinoma in adults : expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol 31 : 1149-1160, 2007
PubMed
7) Zhong M, De Angelo P, Osborne L et al : Translocation renal cell carcinomas in adults : a single-institution experience. Am J Surg Pathol 36 : 654-662, 2012
PubMed
8) Macher-Goeppinger S, Roth W, Wagener N et al : Molecular heterogeneity of TFE3 activation in renal cell carcinomas. Mod Pathol 25 : 308-315, 2012
PubMed
9) Sukov WR, Hodge JC, Lohse CM et al : TFE3 rearrangements in adult renal cell carcinoma : clinical and pathologic features with outcome in a large series of consecutively treated patients. Am J Surg Pathol 36 : 663-670, 2012
 
10) Macher-Goeppinger S, Roth W, Wagener N et al : Molecular heterogeneity of TFE3 activation in renal cell carcinomas. Mod Pathol 25 : 308-315, 2012
PubMed
11) Argani P, Lae M, Ballard ET et al : Translocation carcinomas of the kidney after chemotherapy in childhood. J Clin Oncol 24 : 1529-1534, 2006
PubMed
12) Brassesco MS, Valera ET, Bonilha TA et al : Secondary PSF/TFE3-associated renal cell carcinoma in a child treated for genitourinary rhabdomyosarcoma. Cancer Genet 204 : 108-110, 2011
 
13) Geller JI, Argani P, Adeniran A et al : Translocation renal cell carcinoma : lack of negative impact due to lymph node spread. Cancer 112 : 1607-1616, 2008
PubMed
14) Chang IW, Huang HY, Sung MT : Melanotic Xp11 translocation renal cancer : a case with PSF-TFE3 gene fusion and up-regulation of melanogenetic transcripts. Am J Surg Pathol 33 : 1894-1901, 2009
PubMed
15) Argani P, Aulmann S, Karanjawala Z et al : Melanotic Xp11 translocation renal cancers : a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma. Am J Surg Pathol 33 : 609-619, 2009
PubMed
16) Argani P, Lal P, Hutchinson B et al : Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions : a sensitive and specific immunohistochemical assay. Am J Surg Pathol 27 : 750-761, 2003
PubMed
17) Camparo P, Vasiliu V, Molinie V et al : Renal translocation carcinomas : clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature. Am J Surg Pathol 32 : 656-670, 2008
PubMed
18) Martignoni G, Gobbo S, Camparo P et al : Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions. Mod Pathol 24 : 1313-1319, 2011
PubMed
19) Rao Q, Williamson SR, Zhang S et al : TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone : expanding the morphologic spectrum. Am J Surg Pathol 37 : 804-815, 2013
PubMed
P.77 掲載の参考文献
1) Medeiros LJ : Renal carcinoma associated with neuroblastoma. in Eble JN, Sauter G, Epstein JI et al (eds) : "WHO Classification of Tumours. Pathology & Genetics. Tumours of the Urinary System and Male Genital Organs", IARC Press, Lyon, 2004, p39
 
2) 日本泌尿器科学会, 日本病理学会, 日本医学放射線学会 (編) : 泌尿器科・病理・放射線科 腎癌取扱い規約, 第4版, 金原出版, 2011
 
3) Medeiros LJ, Palmedo G, Krigman HR et al : Oncocytoid renal cell carcinoma after neuroblastoma : a report of four cases of a distinct clinicopathologic entity. Am J Surg Pathol 23 : 772-780, 1999
PubMed
4) Krigman HR, Bentley RC, Strickland DK et al : Anaplastic renal cell carcinoma following neuroblastoma. Med Pediatr Oncol 25 : 52-59, 1995
PubMed
5) Kato K, Ijiri R, Tanaka Y et al : Metachronous renal cell carcinoma in a child cured of neuroblastoma. Med Pediatr Oncol 33 : 432-433, 1999
 
6) Hedgepeth RC, Zhou M, Ross J : Rapid development of metastatic Xp11 translocation renal cell carcinoma in a girl treated for neuroblastoma. J Pediatr Hematol Oncol 31 : 602-604, 2009
 
7) Moreno L, Vaidya SJ, Pinkerton CR et al : Long-term follow-up of children with high-risk neuroblastoma : The ENSG5 trial experience. Pediatr Blood Cancer 60 : 1135-1140, 2013
PubMed
8) Selle B, Furtwangler R, Graf N et al : Population-based study of renal cell carcinoma in children in Germany, 1980-2005 : more frequently localized tumors and underlying disorders compared with adult counterparts. Cancer 107 : 2906-2914, 2006
PubMed
9) Dhall D, Al-Ahmadie HA, Dhall G et al : Pediatric renal cell carcinoma with oncocytoid features occurring in a child after chemotherapy for cardiac leiomyosarcoma. Urology 70 : 178.e13-15, 2007
 
P.85 掲載の参考文献
1) Srigley JR : Mucinous tubular and spindle cell carcinoma. in Eble JN, Sauter G, Epstein JI et al (eds) : "WHO Classification of Tumours. Pathology & Genetics. Tumours of the Urinary System and Male Genital Organs", IARC Press, Lyon, 2004, p40
 
2) MacLennan GT, Farrow GM, Bostwick DG : Low-grade collecting duct carcinoma of the kidney : report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin. Urology 50 : 679-684, 1997
PubMed
3) Parwani AV, Husain AN, Epstein JI et al : Low-grade myxoid renal epithelial neoplasms with distal nephron differentiation. Hum Pathol 32 : 506-512, 2001
PubMed
4) Argani P, Netto GJ, Parwani AV : Papillary renal cell carcinoma with low-grade spindle cell foci : a mimic of mucinous tubular and spindle cell carcinoma. Am J Surg Pathol 32 : 1353-1359, 2008
 
5) Kuroda N, Hes O, Michal M et al : Mucinous tubular and spindle cell carcinoma with Fuhrman nuclear grade 3 : A histological, immunohistochemical, ultrastructural and FISH study. Histol Histopathol 23 : 1517-1523, 2008
PubMed
6) Kuroda N, Naroda T, Tamura M et al : High-grade mucinous tubular and spindle cell carcinoma : comparative genomic hybridization study. Ann Diagn Pathol 15 : 472-475, 2011
PubMed
7) Pillay N, Ramdial PK, Cooper K et al : Mucinous tubular and spindle cell carcinoma with aggressive histomorphology-a sarcomatoid variant. Hum Pathol 39 : 966-969, 2008
PubMed
8) Thway K, du Parcq J, Larkin JM et al : Metastatic renal mucinous tubular and spindle cell carcinoma. Atypical behavior of a rare, morphologically bland tumor. Ann Diagn Pathol 16 : 407-410, 2012
PubMed
9) Hoffmann NE, Sheinin Y, Lohse CM et al : External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma. Cancer 112 : 1471-1479, 2008
PubMed
10) Jiang Z, Lohse CM, Chu PG et al : Oncofetal protein IMP3 : a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas. Cancer 112 : 2676-2682, 2008
PubMed
P.87 掲載の参考文献
1) Eble JN, Moch H : Papillary adenoma of the kidney. in Eble JN, Sauter G, Epstein JI et al (eds) : "WHO Classification of Tumours. Pathology & Genetics. Tumours of the Urinary System and Male Genital Organs", IARC Press, Lyon, 2004, pp41
 
2) Stoerkel S, Eble JN, Adlakha K et al : Classification of renal cell carcinoma : Workgroup No.1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80 : 987-989, 1997
 
3) Olgac S, Hutchinson B, Tickoo SK et al : Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma. Mod Pathol 19 : 218-224, 2006
 
4) Brunelli M, Eble JN, Zhang S et al : Gains of chromosomes 7, 17, 12, 16, and 20 and loss of Y occur early in the evolution of papillary renal cell neoplasia : a fluorescent in situ hybridization study. Mod Pathol 16 : 1053-1059, 2003
PubMed
P.94 掲載の参考文献
1) Zippel L : Zur Kenntnis der Onkocyten. Virchow Arch 308 : 360-382, 1942
 
2) Klein MJ, Valensi QJ : Proximal tubular adenomas of kidney with so-called oncocytic features. A clinicopathologic study of 13 cases of a rarely reported neoplasm. Cancer 38 : 906-914, 1976
PubMed
3) Perez-Ordonez B, Hamed G, Campbell S et al : Renal oncocytoma : a clinicopathologic study of 70 cases. Am J Surg Pathol 21 : 871-883, 1997
PubMed
4) Amin MB, Crotty TB, Tickoo SK et al : Renal oncocytoma : a reappraisal of morphologic features with clinicopathologic findings in 80 cases. Am J Surg Pathol 21 : 1-12, 1997
PubMed
5) Yusenko MV : Molecular pathology of renal oncocytoma : a review. Int J Urol 17 : 602-612, 2010
PubMed
6) Kuroda N, Toi M, Hiroi M et al : Review of renal oncocytoma with focus on clinical and pathobiological aspects. Histol Histopathol 18 : 935-942, 2003
PubMed
7) Trpkov K, Yilmaz A, Uzer D et al : Renal oncocytoma revisited : a clinicopathological study of 109 cases with emphasis on problematic diagnostic features. Histopathology 57 : 893-906, 2010
PubMed
8) 黒田直人, 長嶋洋治 : 嫌色素性腎細胞癌とオンコサイトーマ. 病理と臨床 28 : 1043-1047, 2010
Medical*Online
9) Hes O, Michal M, Shima R et al : Renal oncocytoma with and without intravascular extension into the branches of renal vein have the same morphological, immunohistochemical, and geneticfeatures. Virchows Arch 452 : 285-293, 2008
 
10) Waldert M, Klatte T, Haitel A et al : Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes. Eur Urol 57 : 661-665, 2010
PubMed
11) Petts G, Rashid T, Hrouda D et al : Tumour-to-tumour metastases : prostate carcinoma metastasising to a renal oncocytoma. BMJ Case Rep 2013 (full)
 
12) Cochand-Priollet B, Molinie V, Bougaran J et al : Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases. Arch Pathol Lab Med 121 : 1081-1086, 1997
PubMed
13) Bonsib SM, Bromley C, Lager DJ : Renal oncocytoma : diagnostic utility of cytokeratin-containing globular filamentous bodies. Mod Pathol 4 : 16-23, 1991
PubMed
14) Huo L, Sugimura J, Tretiakova MS et al : C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas. Hum Pathol 36 : 262-268, 2005
PubMed
15) Ohe C, Kuroda N, Takasu K et al : Utility of immunohistochemical analysis of KAI1, epithelial-specific antigen, and epithelial-related antigen for distinction of chromophobe renal cell carcinoma, an eosinophilic variant from renal oncocytoma. Med Mol Morphol 45 : 98-104, 2012
PubMed
16) Truong LD, Shen SS : Immunohistochemical diagnosis of renal neoplasms. Arch Pathol Lab Med 135 : 92-109, 2011
PubMed
17) Kuroda N, Tanaka A, Ohe C et al : Review of renal oncocytosis (multiple oncocytic lesions) with focus on clinical and pathobiological aspects. Histol Histopathol 27 : 1407-1412, 2012
PubMed
18) Petersson F, Sima R, Grossmann P et al : Renal small cell oncocytoma with pseudorosettes A histomorphologic, immunohistochemical, and molecular genetic study of 10 cases. Hum Pathol 42 : 1751-1760, 2011
PubMed
19) Kuroda N, Tanaka A, Yamaguchi T et al : Chromophobe renal cell carcinoma, oncocytic variant : a proposal of a new variant giving a critical diagnostic pitfall in diagnosing renal oncocytic tumors. Med Mol Morphol 46 : 49-55, 2013
PubMed
20) Petersson F, Gatalica Z, Grossmann P et al : Sporadic hybrid oncocytic/chromophobe tumor of the kidney : a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases. Virchows Arch 456 : 355-365, 2010
PubMed
P.99 掲載の参考文献
1) Eble JN, Grignon DJ, Moch H : Metanephric adenoma and metanephric adenofibroma. in Eble JN, Sauter G, Epstein JI et al (eds) : "WHO Classification of Tumours. Pathology & Genetics. Tumours of the Urinary System and Male Genital Organs", IARC Press, Lyon, 2004, pp44-46
 
2) Pages A, Granier M : Le nephrome nephronogene. Arch Anat Cytol Pathol 28 : 99-103, 1980
PubMed
3) Argani P : Metanephric neoplasms : the hyperdifferentiated, benign end of the Wilms tumor spectrum? Clin Lab Med 25 : 379-392, 2005
PubMed
4) Nagashima Y, Arai N, Tanaka Y et al : Two cases of renal epithelial tumours resembling immature nephron. Virch Arch [A] 418 : 77-81, 1991
 
5) Davis CJ Jr, Barton JH, Sesterhenn IA et al : Metanephric adenoma. Clinicopathological study of fifty patients. Am J Surg Pathol 19 : 1101-1114, 1995
 
6) 森山浩之, 吉野干城, 米原修治他 : 腎癌との鑑別が困難であった後腎性腺腫の1例. 西日本泌尿器科 74 : 90-95, 2012
Medical*Online
7) Ogata K, Hajikano H, Sakaguchi H : So-called embryonal hyperplasia of Bowman's capsular epithelium : an immunohistochemical and ultrastructural study. Virchows Arch A Pathol Anat Histopathol 418 : 143-147, 1991
 
8) Renshaw AA, Freyer DR, Hammers YA : Metastatic metanephric adenoma in a child. Am J Surg Pathol 24 : 570-574, 2000
 
P.103 掲載の参考文献
1) 日本泌尿器科学会, 日本病理学会, 日本医学放射線学会 (編) : 泌尿器科・病理・放射線科 腎癌取扱い規約, 第4版, 金原出版, 2011
 
2) Cheville JC, Lohse CM, Zincke H et al : Sarcomatoid renal cell carcinoma : an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol 28 : 435-441, 2004
 
3) Ro JY, Ayala AG, Sella A et al : Sarcomatoid renal cell carcinoma : clinicopathologic. A study of 42 cases. Cancer 59 : 516-526, 1987
PubMed
4) Delahunt B : Advances and controversies in grading and staging of renal cell carcinoma. Mod Pathol 22 (Suppl 2) : S24-S36, 2009
 
5) DeLong W, Grignon DJ, Eberwein P et al : Sarcomatoid renal cell carcinoma. An immunohistochemical study of 18 cases. Arch Pathol Lab Med 117 : 636-640, 1993
PubMed
6) Mikami S, Katsube K, Oya M et al : Expression of Snail and Slug in renal cell carcinoma : E-cadherin repressor Snail is associated with cancer invasion and prognosis. Lab Invest 91 : 1443-1458, 2011
PubMed
P.107 掲載の参考文献
1) Dijkhuizen T, van den Berg E, Strorkel S et al : Two cases of renal cell carcinoma, clear cell type, revealing a t (6 ; 11) (p21 ; q13). Cancer Genet Cytogenet 91 : 141, 1996
 
2) Argani P, Hawkins A, Griffin CA et al : A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t (6 ; 11) (p21.1 ; q12) chromosome translocation. Am J Pathol 158 : 2089-2096, 2001
 
3) Argani P, Lae M, Hutchinson B et al : Renal carcinomas with the t (6 ; 11) (p21 ; q12). Clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am J Surg Pathol 29 : 230-240, 2005
 
4) Eble JN, Sauter G, Epstein JI et al (eds) : WHO Classification of Tumours. Pathology & Genetics. Tumours of the Urinary System and Male Genital Organs, IARC Press, Lyon, 2004
 
5) Petersson F, Venecek T, Michal M et al : A distinctive translocation carcinoma of the kidney ; "rosette forming", t (6 ; 11), HMB45-positive renal tumor : a histomorphologic, immunohistochemical, ultrastructural, and molecular genetic study of 4 cases. Hum Pathol 43 : 726-736, 2012
 
6) Ishihara A, Yamashita Y, Takamori H et al : Renal carcinoma with (6 ; 11) (p21 ; q12) translocation : report of an adult case. Pathol Int 61 : 539-545, 2011
PubMed
7) Argani P, Yonescu R, Morsberger L et al : Molecular confirmation of t (6 ; 11) (p21 ; q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB assay expands its clinicopathologic spectrum. Am J Surg Pathol 36 : 1516-1526, 2012
PubMed
8) Rao Q, Liu B, Cheng L et al : Renal cell carcinoma with t (6 ; 11) (p21 ; q12), A clinicopathologic study emphasizing unusual morphology, novel Alpha-TFEB gene fusion point, immunobiomarkers, and ultrastructural features, as well as detection of the gene fusion by fluorescence in situ hybridization. Am J Surg Pathol 36 : 1327-1338, 2012
 
9) Inamura K, Fujiwara M, Togashi Y et al : Diverse fusion patterns and heterogeneous clinicopathologic features of renal cell carcinoma with t (6 ; 11) translocation. Am J Surg Pathol 36 : 35-42, 2012
 
10) Argani P, Lae M, Ballard ET et al : Translocation carcinomas of the kidney after chemotherapy in childhood. J Clin Oncol 24 : 1529-1534, 2006
PubMed
P.113 掲載の参考文献
1) Soda M, Choi Y, Mano H et al : Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448 : 561-566, 2007
PubMed
2) Shaw AT, Yeap BY, Camidge DR et al : Effect of crizotinib on overall survival in patients with advanced non-smallcell lung cancer harbouring ALK gene rearrangement : a retrospective analysis. Lancet Oncol 12 : 1004-1012, 2011
 
3) Chiarle R, Voena C, Inghirami G et al : The anaplastic lymphoma kinase in the pathogenesis of cancer. Nat Rev Cancer 8 : 11-23, 2008
PubMed
4) Takeuchi K, Mano H, Ishikawa Y et al : Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK : reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification. Clin Cancer Res 17 : 3341-3348, 2011
PubMed
5) Takeuchi K, Choi Y, Mano H et al : KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer. Clin Cancer Res 15 : 3143-3149, 2009
PubMed
6) Takeuchi K, Soda M, Togashi Y et al : RET, ROS1 and ALK fusions in lung cancer. Nat Med 18 : 378-381, 2012
PubMed
7) Sugawara E, Kuroda N, Takeuchi K et al : Identification of anaplastic lymphoma kinase fusions in renal cancer : large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method. Cancer 118 : 4427-4436, 2012
PubMed
8) Debelenko LV, Raimondi SC, Daw N et al : Renal cell carcinoma with novel VCL-ALK fusion : new representative of ALK-associated tumor spectrum. Mod Pathol 24 : 430-442, 2011
PubMed
9) Marino-Eniquez A, Ou WB, Perez-Atayde AR et al : ALK rearrangement in sickle cell trait-associated renal medullary carcinoma. Genes Chromosomes Cancer 50 : 146-153, 2011
 
10) Yang XJ, Tan MH, Kim HL et al : A molecular classification of papillary renal cell carcinoma. Cancer Res 65 : 5628-5637, 2005
PubMed
11) Martelli MP, Sozzi G, Falini B et al : EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues. Am J Pathol 174 : 661-670, 2009
PubMed
P.117 掲載の参考文献
1) Amin MB, MacLennan GT, Gupta R et al : Tubulocystic carcinoma of the kidney : clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma. Am J Surg Pathol 33 : 384-392, 2009
PubMed
2) Osunkoya AO, Young AN, Wang W at al : Comparison of gene expression profiles in tubulocystic carcinoma and collecting duct carcinoma of the kidney. Am J Surg Pathol 33 : 1103-1106, 2009
 
3) Zhou M, Yang XJ, Lopez JI et al : Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma : implications for pathologic classification. Am J Surg Pathol 33 : 1840-1849, 2009
PubMed
4) Azoulay S, Vieillefond A, Paraf F et al : Tubulocystic carcinoma of the kidney : a new entity among renal tumors. Virchows Arch 451 : 905-909, 2007
PubMed
5) Yang XJ, Zhou M, Hes O et al : Tubulocystic carcinoma of the kidney : clinicopathologic and molecular characterization. Am J Surg Pathol 32 : 177-187, 2008
PubMed
6) Srigley JR, Delahunt B : Uncommon and recently described renal carcinomas. Mod Pathol 22 : S2-S23, 2009
PubMed
7) Mego M, Sycova-Mila Z, Rejlekova K et al : Sunitinib in the treatment of tubulocystic carcinoma of the kidney. A case report. Ann Oncol 19 : 1655-1656, 2008
 
P.123 掲載の参考文献
1) Birt AR, Hogg GR, Dube WJ : Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol 113 : 1674-1677, 1977
PubMed
2) Hornstein OP, Knickenberg M : Perifollicular fibromatosis cutis with polyps of the colon-a cutaneo-intestinal syndrome sui generis. Arch Dermatol Res 253 : 161-175, 1975
 
3) Happle R : Hornstein-Birt-Hogg-Dube syndrome : a renaming and reconsideration. Am J Med Genet A 158A : 1247-1251, 2012
PubMed
4) Nickerson ML, Warren MB, Toro JR et al : Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome. Cancer Cell 2 : 157-164, 2002
 
5) Toro JR, Wei MH, Glenn GM et al : BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube syndrome : a new series of 50 families and a review of published reports. J Med Genet 45 : 321-331, 2008
 
6) Toro JR, Pautler SE, Stewart L et al : Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dube syndrome. Am J Respir Crit Care Med 175 : 1044-1053, 2007
PubMed
7) Zbar B, Alvord WG, Glenn G et al : Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dube syndrome. Cancer Epidemiol Biomarkers Prev 11 : 393-400, 2002
PubMed
8) Schmidt LS, Nickerson ML, Warren MB et al : Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dube syndrome. Am J Hum Genet 76 : 1023-1033, 2005
PubMed
9) Furuya M, Nakatani Y : Birt-Hogg-Dube syndrome : clinicopathological features of the lung. J Clin Pathol 66 : 178-186, 2013
 
10) Adley BP, Smith ND, Nayar R et al : Birt-Hogg-Dube syndrome : clinicopathologic findings and genetic alterations. Arch Pathol Lab Med 130 : 1865-1870, 2006
PubMed
11) Pavlovich CP, Walther MM, Eyler RA et al : Renal tumors in the Birt-Hogg-Dube syndrome. Am J Surg Pathol 26 : 1542-1552, 2002
PubMed
12) Nagashima Y, Furuya M, Gotohda H et al : FLCN genemutated renal cell neoplasms : mother and daughter cases with a novel germline mutation. Int J Urol 19 : 468-470, 2012
 
13) Kuroda N, Tanaka A, Ohe C et al : Review of renal oncocytosis (multiple oncocytic lesions) with focus on clinical and pathobiological aspects. Histol Histopathol 27 : 1407-1412, 2012
PubMed
14) Furuya M, Tanaka R, Koga S et al : Pulmonary cysts of Birt-Hogg-Dube syndrome : A clinicopathologic and immunohistochemical study of 9 families. Am J Surg Pathol 36 : 589-600, 2012
PubMed
15) Murakami T, Sano F, Huang Y et al : Identification and characterization of Birt-Hogg-Dube associated renal carcinoma. J Pathol 211 : 524-531, 2007
PubMed
16) Klomp JA, Petillo D, Niemi NM et al : Birt-Hogg-Dube renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression. BMC Med Genomics 3 : 59, 2010
PubMed
17) Menko FH, Johannesma PC, van Moorselaar RJ et al : A de novo FLCN mutation in a patient with spontaneous pneumothorax and renal cancer ; a clinical and molecular evaluation. Fam Cancer 2012 Dec 22. [Epub ahead of print]
 
18) Hong SB, Oh H, Valera VA et al : Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization. PLoS One 5 : e15793, 2010
PubMed
19) Menko FH, van Steensel MA, Giraud S et al : Birt-Hogg-Dube syndrome : diagnosis and management. Lancet Oncol 10 : 1199-1206, 2009
PubMed
20) Inoki K, Corradetti MN, Guan KL : Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet 37 : 19-24, 2005
 
21) Baba M, Hong SB, Sharma N et al : Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Proc Natl Acad Sci USA 103 : 15552-15557, 2006
PubMed
22) Hasumi H, Baba M, Hong SB et al : Identification and characterization of a novel folliculin-interacting protein FNIP2. Gene 415 : 60-67, 2008
PubMed
23) Takagi Y, Kobayashi T, Shiono M et al : Interaction of folliculin (Birt-Hogg-Dube gene product) with a novel Fnip1-like (FnipL/Fnip2) protein. Oncogene 27 : 5339-5347, 2008
PubMed
24) Hasumi Y, Baba M, Ajima R et al : Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2. Proc Natl Acad Sci USA 106 : 18722-18727, 2009
PubMed
25) Okimoto K, Sakurai J, Kobayashi T et al : A germ-line insertion in the Birt-Hogg-Dube (BHD) gene gives rise to the Nihon rat model of inherited renal cancer. Proc Natl Acad Sci USA 101 : 2023-2027, 2004
 
26) Nahorski MS, Lim DH, Martin L et al : Investigation of the Birt-Hogg-Dube tumour suppressor gene (FLCN) in familial and sporadic colorectal cancer. J Med Genet 47 : 385-390, 2010
PubMed
27) Shin JH, Shin YK, Ku JL et al : Mutations of the Birt-Hogg-Dube (BHD) gene in sporadic colorectal carcinomas and colorectal carcinoma cell lines with microsatellite instability. J Med Genet 40 : 364-367, 2003
PubMed
28) Kashiwada T, Shimizu H, Tamura K et al : Birt-Hogg-Dube syndrome and familial adenomatous polyposis : an association or a coincidence? Intern Med 51 : 1789-1792, 2012
PubMed
29) Fujii H, Jiang W, Matsumoto T et al : Birt-Hogg-Dube gene mutations in human endometrial carcinomas with microsatellite instability. J Pathol 209 : 328-335, 2006
PubMed
30) Jiang W, Fujii H, Matsumoto T et al : Birt-Hogg-Dube (BHD) gene mutations in human gastric cancer with high frequency microsatellite instability. Cancer Lett 248 : 103-111, 2007
PubMed
31) Moore LE, Wilson RT, Campleman SL : Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer risk : a review. Cancer Invest 23 : 240-255, 2005
 
32) Nishii T, Tanabe M, Tanaka R et al : Unique mutation, accelerated mTOR signaling and angiogenesis in the pulmonary cysts of Birt-Hogg-Dube syndrome. Pathol Int 63 : 45-55, 2013
PubMed
P.130 掲載の参考文献
1) Choyke PL : Acquired cystic kidney disease. Eur Radiol 10 : 1716-1721, 2000
PubMed
2) Denton MD, Magee CC, Ovuworie C et al : Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation. A pathologic analysis. Kidney Int 61 : 2201-2209, 2002
PubMed
3) Nagashima Y, Kuroda N, Yao M : Transition of organizational category on renal cancer. Jpn J Clin Oncol 43 : 233-242, 2013
PubMed
4) Tickoo SK, Mariza N, de Peralta-Venturina MN et al : Spectrum of epithelial neoplasms in end-stage renal disease. An experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 30 : 141-153, 2006
 
5) Gobbo S, Eble JN, Grignon DJ et al : Clear cell papillary renal cell carcinoma. A distinct histopathologic and molecular genetic entity. Am J Surg Pathol 32 : 1239-1245, 2008
PubMed
6) Kuroda N, Tamura M, Taguchi T et al : Sarcomatoid acquired cystic disease-associated renal cell carcinoma. Histol Histopathol 23 : 1327-1331, 2008
PubMed
7) Kuroda N, Tamura M, Hamaguchi N et al : Acquired cystic disease-associated renal cell carcinoma with sarcomatoid change and rhabdoid features. Ann Diagn Pathol 15 : 462-466, 2011
PubMed
8) Ahn S, Kwon GY, Cho YM et al : Acquired cystic diseaseassociated renal cell carcinoma. Further characterization of the morphologic and immunopathologic features. Med Mol Morphol 2013, Mar 8 [Epub ahead of print]
 
9) Sule N, Yakupoglu, U, Shen SS et al : Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease. A comparative study. Am J Surg Pathol 29 : 443-451, 2005
 
10) Cossu-Rocca P, Eble JN, Zhang S et al : Acquired cystic disease-associated renal tumors. An immunohistochemical and fluorescence in situ hybridization study. Mod Pathol 19 : 780-787, 2006
 
11) Pan CC, Chen YJ, Chang YH et al : Immunohistochemical and molecular genetic profiling of acquired cystic diseaseassociated renal cell carcinoma. Histopathology 55 : 145-153, 2009
PubMed
12) Kuroda N, Yamashita M, Kakehi Y et al : Acquired cystic disease-associated renal cell carcinoma. An immunohistochemical and fluorescence in situ hybridization study. Med Mol Morphol 44 : 228-232, 2011
PubMed
13) Rohan SM, Xiao Y, Liang Y et al : Clear cell papillary renal cell carcinoma. Molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. Mod Pathol 24 : 1207-1220, 2011
 
14) Park JH, Lee C, Suh JH et al : Clear cell papillary renal cell carcinoma. A report of 15 cases including three cases of concurrent other-type renal cell carcinomas. Korean J Pathol 46 : 541-547, 2012
 
15) Kuroda N, Shiotsu T, Hes O et al : Acquired cystic diseaseassociated renal cell carcinoma with gain of chromosomes 3, 7, and 16, gain of chromosome X, and loss of chromosome Y. Med Mol Morphol 43 : 231-234, 2010
PubMed
16) Yamaguchi T, Kuroda N, Kawada T et al : Imprint cytological findings of acquired cystic disease-associated renal cell carcinoma. A close relationship to papillary renal cell carcinoma. Diagn Cytopathol 40 : 844-846, 2012
PubMed
17) Cheuk W, Lo ES, Chan AK et al : Atypical epithelial proliferations in acquired renal cystic disease harbor cytogenetic aberrations. Hum Pathol 33 : 761-765, 2002
PubMed
18) Inoue T, Matsuura K, Yoshimoto T et al : Genomic profiling of renal cell carcinoma in patients with end-stage renal disease. Cancer Sci 103 : 569-576, 2012
PubMed
19) Nouh MA, Kuroda N, Yamashita N et al : Renal cell carcinoma in patients with end-stage renal disease. Relationship between histological type and duration of dialysis. BJU Int 105 : 620-627, 2010
 
P.133 掲載の参考文献
1) Amin MB, McKenny JK, Tickoo SK et al (eds) : Diagnostic Pathology : Geniturinary, Amirsys, Canada, 2010, pp1-198-201
 
2) Romero FR, Rais-Bahrami S, Permpongkosol S et al : Primary carcinoid tumors of the kidney. J Urol 176 : 2359-2366, 2006
PubMed
3) Murali R, Kneale K, Lalak N : Carcinoid tumors of the urinary tract and prostate. Arch Pathol Lab Med 130 : 1693-1706, 2006
PubMed
4) Kuroda N, Tanaka A, Ohe C et al : Review of renal carcinoid tumor with focus on clinical and pathobiological aspects. Histol Histopathol 28 : 15-21, 2013
PubMed
5) Hansel DE, Epstein JI, Berbescu E et al : Renal carcinoid tumor : A clinicopathologic study of 21 cases. Am J Surg Pathol 31 : 1539-1544, 2007
PubMed
P.137 掲載の参考文献
1) Tetu B : Juxtaglomerular cell tumour. in Eble JN, Sauter G, Epstein I et al (eds) : "WHO Classification of Tumours of the Urinary System and Male General Organs", IARC Press, Washington DC, 2004, pp72-73
 
2) Murphy WM, Grignon DJ, Perlman EJ : AFIP Atlas of Tumor Pathology, Series 4, Tumors of the Kidney, Bladder, and Related Urinary Structures, ARP, Washington, DC, 2004, pp178-181
 
3) Robertson PW, Klidjian A, Harding LK et al : Hypertension due to a renin-secreting tumor. Am J Med 43 : 963-976, 1967
PubMed
4) Katabathina VS, Raghunandan V, Nagar M et al : Mesenchymal neoplasms of the kidney in aduls : imaging spectrum with radiologic-pathologic correlation. Genitourinary Imaging 30 : 1525-1540, 2010
 
5) Kihara I, Kitamura S, Hoshino T et al : A hitherto unreported vascular tumor of the kidney : A proposal of "Juxtaglomerular cell tumor". Acta Pathol Jpn 18 : 197-206, 1968
PubMed
6) Sakata R, Shimoyamada H, Yanagisawa M et al : Nonfunctioning juxtaglomerular cell tumor. Case Rep Pathol 2013, March 27 (PMC free article)
 
7) Beaudoin J, Perigny M, Tetu B et al : A patient with a juxtaglomerular cell tumor with histological vascular invasion, Nat Clin Pract Nephrol 4 : 458-462, 2008
PubMed
8) Duan X, Bruneval P, Clark JI et al : Metastatic juxtaglomerular cell tumor in a 52-year-old man. Am J Surg Pathol 28 : 1098-1102, 2004
 
9) 三上修治 : 注意すべき腎非上皮性腫瘍, 混合腫瘍. 病理と臨床 28 : 1060-1066, 2010
Medical*Online
10) Kuroda N, Gotoda H, Ohe C et al : Review of juxtaglomerular cell tumor with focus on pathological aspect. Diagn Pathol 6 : 80, 2011
PubMed
11) Brandel P, Busund LT, Heim S : Chromosome abnormalities in juxtaglomerular cell tumors. Cancer 104 : 504-510, 2004
 
12) Capovilla M, Couturier J, Molinie V et al : Loss of chromosomes 9 and 11 may be recurrent chromosome imbalances in juxtaglomerular cell tumors. Hum Pathol 39 : 459-462, 2008
PubMed
13) Kuroda N, Maris S, Monzon FA et al : Juxtaglomerular cell tumor : A morphological, immunohistochemical and genetic study of six cases. Hum Pathol 44 : 47-54, 2012
PubMed
P.143 掲載の参考文献
1) Eble JN : Angiomyolipoma of kidney. Semin Diagn Pathol 15 : 21-40, 1998
PubMed
2) Crino PB, Nathanson KL, Henske EP : The tuberous sclerosis complex. N Engl J Med 355 : 1345-1356, 2006
PubMed
3) Green AJ, Sepp T, Yates JR : Clonality of tuberous sclerosis harmatomas shown by non-random X-chromosome inactivation. Hum Genet 97 : 240-243, 1996
PubMed
4) Cheng L, Gu J, Eble JN et al : Molecular genetic evidence for different clonal origin of components of human renal angiomyolipomas. Am J Surg Pathol 25 : 1231-1236, 2001
PubMed
5) Bonetti F, Pea M, Martignoni G et al : The perivascular epithelioid cell and related lesions. Adv Anat Pathol 4 : 343-358, 1997
 
6) Martignoni G, Amin MB : Angiomyolipoma. in Eble JN, Sauter G, Epstein JI et al (eds) : "WHO Classification of Tumours. Pathology and Genetics. Tumours of the Urinary System and Male Genital Ogans", IARC Press, Lyon, 2004, pp65-67
 
7) Steiner MS, Goldman SM, Fishman EK et al : The natural history of renal angiomyolipoma. J Urol 150 : 1782-1786, 1993
PubMed
8) Hornick JL, Fletcher CD : Sclerosing PEComa : clinicopathologic analysis of a distinctive variant with a predilection for the retroperitoneum. Am J Surg Pathol 32 : 493-501, 2008
PubMed
9) Mukai M, Torikata C, Iri H et al : Crystalloids in angiomyolipoma. 1. A previously unnoticed phenomenon of renal angiomyolipoma occurring at a high frequency. Am J Surg Pathol 16 : 1-10, 1992
 
10) Bonsib SM, Moghadamfalahi M, Bhalodia A : Lymphatic differentiation in renal angiomyolipomas. Hum Pathol 40 : 374-380, 2009
PubMed
11) Matsuyama A, Hisaoka M, Ichikawa K et al : Sclerosing variant of epithelioid angiomyolipoma. Pathol Int 58 : 306-310, 2008
PubMed
12) Davis CJ, Barton JH, Sesterhenn IA : Cystic angiomyolipoma of the kidney : a clinicopathologic description of 11 cases. Mod Pathol 19 : 669-674, 2006
 
13) Martignoni G, Pea M, Bonetti F et al : Oncocytoma-like angiomyolipoma. A clinicopathologic and immunohistochemical study of 2 cases. Arch Pathol Lab Med 126 : 610-612, 2002
PubMed
14) Nagashima Y, Ohaki Y, Tanaka Y et al : A case of renal angiomyolipomas associated with multiple and various hamartomatous microlesions. Virchows Arch A Pathol Anat Histopathol 413 : 177-182, 1988
PubMed
15) Barnard M, Lajoie G : Angiomyolipoma : immunohistochemical and ultrastructural study of 14 cases. Ultrastruct Pathol 25 : 21-29, 2001
PubMed
16) Roma AA, Magi-Galluzzi C, Zhou M : Differential expression of melanocytic markers in myoid, lipomatous, and vascular components of renal angiomyolipomas. Arch Pathol Lab Med 131 : 122-125, 2007
PubMed
17) Karafin M, Parwani AV, Netto GJ et al : Diffuse expression of PAX2 and PAX8 in the cystic epithelium of mixed epithelial stromal tumor, angiomyolipoma with epithelial cysts, and primary renal synovial sarcoma : evidence supporting renal tubular differentiation. Am J Surg Pathol 35 : 1264-1273, 2011
PubMed
18) Jimenez RE, Eble JN, Reuter VE et al : Concurrent angiomyolipoma and renal cell neoplasia : a study of 36 cases. Mod Pathol 14 : 157-163, 2001
PubMed
P.148 掲載の参考文献
1) Amin MB : Epithelioidangiomyolipoma. in Eble JN, Sauter G, Epstein JI et al (eds) : "WHO Classification of Tumours. Pathology & Genetics. Tumours of the Urinary System and Male Genital Organs", IARC Press, Lyon, 2004, pp68-69
 
2) Martigoni G, Pea M, Reghellin D et al : PEComas : the past, the present and the future. Virchows Arch 452 : 119-132, 2008
 
3) Aydin H, Magi-Galluzzi C, Lane BR et al : Renal angiomyolipoma : clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association. Am J Surg Pathol 33 : 289-297, 2009
PubMed
4) Nese N, Martignoni G, Fletcher CD et al : Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney : a clinicopathologic study of 41 cases : detailed assessment of morphology and risk stratification. Am J Surg-Pathol 35 : 161-176, 2011
PubMed
5) Kato I, Inayama Y, Yamanaka S et al : Epithelioid angiomyolipoma of the kidney. Pathol Int 59 : 38-43, 2009
PubMed
6) Matsuyama A, Hisaoka M, Ichikawa K et al : Sclerosing variant of epithelioid angiomyolipoma. Pathol Int 58 : 306-310, 2008
PubMed
7) Chang H, Jung W, Kang Y et al : Pigmented perivascular epithelioid cell tumor (PEComa) of the kidney : a case report and review of the literature. Korean J Pathol 46 : 499-502, 2012
 
8) Ohe C, Kuroda N, Hes O et al : A renal epithelioid angiomyolipoma/perivascular epithelioid cell tumor with TFE3 gene break visualized by FISH. Med Mol Morphol 45 : 234-237, 2012
PubMed
9) Brimo F, Robinson B, Guo C et al : Renal epithelioid angiomyolipoma with atypia : a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy. Am J Surg Pathol 34 : 715-722, 2010
PubMed
10) Argani P, Aulmann S, Karanjawala Z et al : Melanotic Xp11 translocation renal cell cancers : a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma. Am J Surg Pathol 33 : 609-619, 2009
PubMed
11) Martigoni G, Bonetti F, Chilosi M et al : Cathepsin K expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney. Mod Pathol 25 : 100-111, 2012
 
12) Folpe AL, Mentzel T, Lehr HA et al : Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin : a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol 29 : 1558-1575, 2005
PubMed
P.152 掲載の参考文献
1) Eble JN, Bonsib SM : Extensively cystic renal neoplasms : cystic nephroma, cystic partially differentiated nephroblastoma, multilocular cystic renal cell carcinoma, and cystic hamartoma of renal pelvis. Semin Diagn Pathol 15 : 2-20, 1998
PubMed
2) Michal M, Syrucek M : Benign mixed epithelial and stromal tumor of the kidney. Pathol Res Pract 194 : 445-448, 1998
PubMed
3) Michal M : Benign mixed epithelial and stromal tumor of the kidney. Pathol Res Pract 196 : 275-276, 2000
PubMed
4) Adsay NV, Eble JN, Srigley JR et al : Mixed epithelial and stromal tumor of the kidney. Am J Surg Pathol 24 : 958-970, 2000
PubMed
5) Antic T, Perry KT, Harrison K et al : Mixed epithelial and stromal tumor of the kidney and cystic nephroma share overlapping features : reappraisal of 15 lesions. Arch Pathol Lab Med 130 : 80-85, 2006
PubMed
6) Jevremovic D, Lager DJ, Lewin M : Cystic nephroma (multilocular cyst) and mixed epithelial and stromal tumor of the kidney : a spectrum of the sameentity? Ann Diagn Pathol 10 : 77-82, 2006
PubMed
7) Turbiner J, Amin MB, Humphrey PA et al : Cystic nephroma and mixed epithelial and stromal tumor of kidney : a detailed clinicopathologic analysis of 34 cases and proposal for renal epithelial and stromal tumor (REST) as a unifying term. Am J Surg Pathol 31 : 489-500, 2007
PubMed
8) Zhou M, Kort E, Hoekstra P et al : Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney are the same disease entity : molecular and histologic evidence. Am J Surg Pathol 33 : 72-80, 2009
PubMed
9) Lane BR, Campbell SC, Remer EM et al : Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney : clinical, radiographic, and pathologic characteristics. Urology 71 : 1142-1148, 2008
PubMed
10) Sahni VA, Mortele KJ, Glickman J et al : Mixed epithelial and stromal tumour of the kidney : imaging features. BJU Int 105 : 932-939, 2010
PubMed
11) Beiko DT, Nickel JC, Boag AH et al : Benign mixed epithelial stromal tumor of the kidney of possible mullerian origin. J Urol 166 : 1381-1382, 2001
PubMed
12) Yang Y, Ondrej H, Zhang L et al : Mixed epithelial and stromal tumor of the kidney with cervical and intestinal differentiation. Virchows Arch 447 : 669-671, 2005
PubMed
13) Pierson CR, Schober MS, Wallis T et al : Mixed epithelial and stromal tumor of the kidney lacks the genetic alterations of cellular congenital mesoblastic nephroma. Hum Pathol 32 : 513-520, 2001
PubMed
14) Kum JB, Grignon DJ, Wang M et al : Mixed epithelial and stromal tumors of the kidney : evidence for a single cell of origin with capacity for epithelial and stromal differentiation. Am J Surg Pathol 35 : 1114-1122, 2011
PubMed
P.155 掲載の参考文献
1) Amin MB, McKenny JK, Tickoo SK et al (eds) : Diagnostic Pathology Genitourinary, Amirsys, Canada, 2010, pp1-216-217
 
2) Murphy WM, Grignon DJ, Perlman EJ : AFIP Atlas of Tumor Pathology Series 4, Tumors of the Kidney, Bladder, and Related Urinary Structures, ARP, Washinton DC, 2004, pp194-195
 
3) Agas K, Tuncel A, Aslan Y, et al : Adolescent renomedullary interstitial cell tumor : a case report. Tumori. 91 : 555-557, 2005
 
4) Horita Y, Tadokoro M, Taura K et al : Incidental detection of renomedullary interstitial cell tumor in a renal biopsy specimen. Nephrol Dial Transplant 19 : 1007-1008, 2004
 
5) Eble JN : Renomedullary interstitial cell tumor. in Eble JN, Sauder G, Epstein JI et al (eds) : "WHO Classification of Tumours. Pathology & Genetics. Tumours of the Urinary System and Male Genital Organs", Lyon, 2002, p75
 
6) Faris G, Nashishibi M, Friedman B et al : Urosepsis as a presenting symptom of renomedullary interstitial cell tumor causing renal obstruction. IMAJ 11 : 509-510, 2009
 
7) Mai KT : Giant renomedullary interstitial cell tumor. J Urol 151 : 986-988, 1994
PubMed
8) Pecorella I, Lucas SB, Ciardi A et al : Calcium oxalate precipitates in a renomedullary interstitial cell tumor. Pathol Oncol Res 9 : 47-48, 2003
 
9) Lerma RJ, Pitcock JA, Stephenson P et al : Renomedullary interstitial cell tumor (formerly fibroma of renal medulla). Hum Pathol 3 : 559-568, 1972
 
P.163 掲載の参考文献
1) Oue T, Fukuzawa M, Okita H et al : Outcome of pediatric renal tumor treated using the Japan Wilms Tumor Study-1 (JWiTS-1) protocol : a report from the JWiTS Group. Pediatr Surg Int 25 : 923-929, 2009
PubMed
2) Pelletier J, Bruening W, Kashtan CE et al : Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67 : 437-447, 1991
PubMed
3) 日本病理学会小児腫瘍組織分類委員会 (編) : 小児腎腫瘍. 小児腫瘍組織カラーアトラス, 第4巻, 金原出版, 2008, pp8-11
 
4) Faria P, Beckwith JB, Mishra K et al : Focal versus diffuse anaplasia in Wilms tumor-new definitions with prognostic significance : a report from the National Wilms Tumor Study Group. Am J Surg Pathol 20 : 909-920, 1996
 
5) Vujanic GM, Sandstedt B : The pathology of Wilms' tumour (nephroblastoma) : the International Society of Paediatric Oncology approach. J Clin Pathol 63 : 102-109, 2010
PubMed
6) 小林庸次 : 腎芽腫症と関連腎芽腫の病理学的検討. 小児外科 24 : 174-182, 1992
 
7) Perlman EJ : Pediatric renal tumors : practical updates for the pathologist. Pediatr Dev Pathol 8 : 320-338, 2005
PubMed
8) Davis JL, Matsumura L, Weeks DA et al : PAX2 expression in Wilms tumors and other childhood neoplasms. Am J Surg Pathol 35 : 1186-1194, 2011
PubMed
9) Muir TE, Cheville JC, Lager DJ : Metanephric adenoma, nephrogenic rests, and Wilms' tumor : a histologic and immunophenotypic comparison. Am J Surg Pathol 25 : 1290-1296, 2001
PubMed
10) Argani P, Beckwith JB : Metanephric stromal tumor : report of 31 cases of a distinctive pediatric renal neoplasm, Am J Surg Pathol 24 : 917-926, 2000
PubMed
11) Arroyo MR, Green DM, Perlman EJ et al : The spectrum of metanephric adenofibroma and related lesions : Clinicopathologic study of 25 cases from the National Wilms Tumor Study Group Pathology Center. Am J Surg Pathol 25 : 433-444, 2001
 
12) Vujanic GM, Kelsey A, Perlman EJ et al : Anaplastic sarcoma of the kidney. A clinicopathologic study of 20 cases of a new entity with polyphenotypic features. Am J Surg Pathol 31, 1459-1468, 2007
PubMed
13) Call KM, Glaser T, Ito CY et al : Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60 : 509-520, 1990
PubMed
14) Haruta M, Arai Y, Sugawara W et al : Duplication of paternal IGF2 or loss of maternal IGF2 imprinting occurs in half of Wilms tumors with various structural WT1 abnormalities. Genes Chromosomes Cancer 47 : 712-727, 2008
PubMed
P.168 掲載の参考文献
1) Bolande RP, Brough AJ, Izant RJ : Congenital mesoblastic nephroma of infancy : a report of eight cases and the relationship to Wilms' tumor. Pediatrics 40 : 272-278, 1967
PubMed
2) Marsden HB, Lawler W : Primary renal tumours in the first year of life : a population based review. Virchows Arch 399 : 1-9, 1983
PubMed
3) Vido L, Carli M, Rizzoni G et al : Congenital mesoblastic nephroma with hypercalcemia. Pathogenetic role of prostaglandins. Am J Pediatr Hematol Oncol 8 : 149-152, 1986
PubMed
4) Miller OF, Kolon TF : Hyperreninemia and congenital mesoblastic nephroma : case report and review of the literature. Urology 55 : 775, 2000
PubMed
5) Heidelberger KP, Ritchey ML, Dauser RC et al : Congenital mesoblastic nephroma metastatic to the brain. Cancer 72 : 2499-2502, 1993
 
6) Vujanic GM, Delemarre JF, Moeslichan S et al : Mesoblastic nephroma metastatic to the lungs and heart-another face of this peculiar lesion : case report and review of the literature. Pediatr Pathol 13 : 143-153, 1993
 
7) Chan HS, Cheng MY, Mancer K et al : Congenital mesoblastic nephroma : a clinicoradiologic study of 17 cases representing the pathologic spectrum of the disease. J Pediatr 111 : 64-70, 1987
 
8) Kelner M, Droulle P, Didier F et al : The vascular "ring" sign in mesoblastic nephroma : report of two cases. Pediatr Radiol 33 : 123-128, 2003
PubMed
9) Riccabona M : Imaging of renal tumours in infancy and childhood. Eur Radiol 13 (Suppl 4) : L116-L129, 2003
 
10) O'Malley DP, Mierau GW, Beckwith JB et al : Ultrastructure of cellular congenital mesoblastic nephroma. Ultrastruct Pathol 20 : 417-427, 1996
PubMed
11) Snyder HM 3rd, Lack EE, Chetty-Baktavizian A et al : Congenital mesoblastic nephroma : relationship to other renal tumors of infancy. J Urol 126 : 513-516, 1981
PubMed
12) Huang CC, Cutcliffe C, Coffin C et al : Classification of malignant pediatric renal tumors by gene expression. Pediatr Blood Cancer 46 : 728-738, 2006
PubMed
13) Knezevich SR, Garnett MJ, Pysher TJ et al : ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res 58 : 5046-5048, 1998
PubMed
14) Anderson J, Gibson S, Sebire NJ : Expression of ETV6-NTRK in classical, cellular and mixed subtypes of congenital mesoblastic nephroma. Histopathology 48 : 748-753, 2006
PubMed
15) Chi HT, Ly BT, Kano Y et al : ETV6-NTRK3 as a therapeutic target of small molecule inhibitor PKC412. Biochem Biophys Res Commun 429 : 87-92, 2012
PubMed
P.173 掲載の参考文献
1) 日本病理学会小児腫瘍組織分類委員会 (編) : 小児腫瘍組織カラーアトラス 第4巻 小児腎腫瘍, 金原出版, 2008, pp26-27
 
2) Argani P, Perlman EJ, Breslow NE et al : Clear cell sarcoma of the kidney : a review of 351 cases from the National Wilms Tumor Study Group Pathology Center. Am J Surg Pathol 24 : 4-18, 2000
 
3) Murphy WM, Grignon DJ, Perlman, EJ : AFIP Atlas of Tumor Pathology, Fourth series, Fascicle 1, Tumors of the Kidney, Bladder, and Related Urinary Structures, ARP, Washington, DC, 2004, pp65-75
 
4) Brownlee NA, Perkins A, Stewart W et al : Recurring translocation (10 ; 17) and deletion (14q) in clear cell sarcoma of the kidney. Arch Pathol Lab Med 131 : 446-451, 2007
 
5) 横森欣司 : 間葉芽腎腫と腎明細胞肉腫との鑑別におけるポイント. 病理と臨床 20 : 788-794, 2002
 
6) Jones C, Rodriguez-Pinilla M, Lambros M et al : c-KIT overexpression, without gene amplification and mutation, in paediatric renal tumours. J Clin Pathol 60 : 1226-1231, 2007
PubMed
P.177 掲載の参考文献
1) Haas JE, Palmer NF, Weinberg AG et al : Ultrastructure of malignant rhabdoid tumor of the kidney. A distinctive renal tumor of children. Hum Pathol 12 : 646-657, 1981
PubMed
2) Weeks DA, Beckwith JB, Mierau GW et al : Rhabdoid tumor of kidney. A report of 111 cases from the National Wilms' Tumor Study Pathology Center. Am J Surg Pathol 13 : 439-458, 1989
 
3) Hollmann TJ, Hornick JL : INI1-deficient tumors : Diagnostic features and molecular genetics, Am J Surg Pathol 35 : e47-e63, 2011
PubMed
4) Dabbs DJ : Diagnostic Immunohistochemistry, 3rd ed, Saunders, Philadelphia, 2010, pp677-680
 
5) Hoot AC, Russo P, Judkins AR et al : Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol 28 : 1485-1491, 2004
PubMed

第3部 鑑別ポイント

P.185 掲載の参考文献
1) Grignon DJ, Eble JN, Bonsib SM et al : Clear cell renal cell carcinoma. in Eble JN, Sauter G, Epstein JI et al (eds) : "WHO Classification of Tumours. Pathology & Genetics. Tumour of the Urinary System and Male Genital Organs", IARC Press, Lyon, 2004, pp23-25
 
2) Nagashima Y, Kuroda N, Yao M : Transition of organization category on renal cancer. Jpn J Clin Oncol 43 : 233-242, 2013
PubMed
3) Argani P, Antonescu CR, Couturier J et al : PRCC-TFE3 renal carcinomas : morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t (X ; 1) (p11.2 ; q21). Am J Surg Pathol 26 : 1553-1566, 2002
 
4) Argani P, Lae M, Hutchinson B et al : Renal carcinomas with the t (6 ; 11) (p21 ; q12) : clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am J Surg Pathol 29 : 230-240, 2005
 
5) Sule N, Yakupoglu U, Shen S et al : Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease. A comprehensive study. Am J Surg Pathol 29 : 443-451, 2005
PubMed
6) Aydin H, Magi-Galluzzi C, Lane BR et al : Renal angiomyolipoma : clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association. Am J Surg Pathol 33 : 289-297, 2009
PubMed
7) Amin MB, Paner GP, Alvarado-Cabrero I et al : Chromophobe renal cell carcinoma : histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases. Am J Surg Pathol 32 : 1822-1834, 2008
PubMed
8) Amin MB, Crotty TB, Tickoo SK et al : Renal oncocytoma : a reappraisal of morphologic features with clinicopathologic findings in 80 cases. Am J Surg Pathol 21 : 1-12, 1997
PubMed
9) Ohe C, Kuroda N, Hes O et al : A renal epithelioid angiomyolipoma/perivascular epithelioid cell tumor with TFE3 gene break visualized by FISH. Med Mod Morphol 45 : 234-237, 2012
 
10) Hes O, Michal M, Sima R et al : Renal oncocytoma with and without intravascular extension into the branches of renal vein have the same morphological, immunohistochemical, and genetic features. Virchows Arch 452 : 285-293, 2008
PubMed
11) Shomori K, Nagashima Y, Kuroda N et al : ARPP is selectively expressed in renal oncocytoma, but rarely in renal cell carcinomas. Mod Pathol 20 : 199-207, 2007
PubMed
12) Kuroda N, Toi M, Hiroi M et al : Review of renal oncocytoma with focus on clinical and pathobiological aspects. Histol Histopathol 18 : 935-942, 2003
PubMed
P.190 掲載の参考文献
1) 大喜多肇 : 小児腎腫瘍. 病理と臨床 30 : 1230-1235, 2012
Medical*Online
2) 田中祐吉 : 小児がん病理診断の実際. 病理と臨床 30 : 1242-1246, 2012
Medical*Online
3) 日本病理学会小児腫瘍組織分類委員会 (編) : 小児腫瘍組織カラーアトラス 第4巻 小児腎腫瘍, 金原出版, 2008, pp8-21
 
4) Tickoo SK, Reuter VE : Metanephric adenoma. in Amin MB, McKenny JK, Tickoo SK et al (eds) : "Diagnostic Pathology Genitourinary", Amirsys, Canada, 2010, pp1-134-139
 
5) 日本病理学会小児腫瘍組織分類委員会 (編) : 小児腫瘍組織カラーアトラス 第4巻 小児腎腫瘍, 金原出版, 2008, pp32-33
 
6) Kawahara T, Sekiguchi Z, Makiyama K et al : Primary synovial sarcoma of the kidney. Case Rep Oncol 2 : 189-193, 2009
PubMed
7) Tickoo SK, Reuter VE : Synovial sarcoma. in Amin MB, McKenny JK, Tickoo SK et al (eds) : "Diagnostic Pathology Genitourinary", Amirsys, Canada, 2010, pp1-194-197
 
8) 神尾多喜浩, 原 一正, 町田二郎他 : 腎臓に発生したperipheral primitive neuroectodermal tumorの一例. 診断病理 26 : 107-110, 2009
 
9) Tickoo SK, Reuter VE : Primitive neuroectodermal tumor. in Amin MB, McKenny JK, Tickoo SK et al (eds) : "Diagnostic Pathology Genitourinary", Amirsys, Canada, 2010, pp1-202-205
 
10) Tickoo SK, Reuter VE : Neuroblastoma (Wilms tumor). in Amin MB, McKenny JK, Tickoo SK et al (eds) : "Diagnostic Pathology Genitourinary", Amirsys, Canada, 2010, pp1-148-157
 
11) Arroyo MR, Green DM, Perlman EJ et al : The spectrum of metanephric adenofibroma and related lesions clinicopathological study of 25 cases from the National Wilms Tumor Study Group Pathology Center. Am J Surg Pathol 25 : 433-444, 2001
 
12) Murphy WM, Grignon DJ, Perlman EJ (eds) : AFIP Atlas of Tumor Pathology Series 4, Fascicle 1. Tumors of the Kidney, Bladder, and Related Urinary Structures, ARP, Washington DC, 2004
 
13) Li L, Parwani AV : Xanthogranulomatous pyelonephritis. Arch Pathol Lab Med 135 : 671-674, 2011
PubMed
13) 秦順一, 浜崎豊, 小林庸次 (編) : 小児がんアトラス, 金原出版, 2010
 
14) Eble JN, Sauter G, Epstein I et al (eds) : WHO Classification of Tumours. Pathology & Genetics. Tumours of the Urinary System and Male Genital Organs, IARC Press, Lyon, 2004
 
P.194 掲載の参考文献
1) Murphy WM, Grignon DJ, Perlmam EJ : AFIP Atlas of Tumor Pathology, Fourth series, Fascicle 1, Tumors of the Kidney, Bladder, and Related Urinary Structures, ARP, Washington, DC, 2004
 
2) Argani P, Olgac S, Tickoo SK et al : Xp11 translocation renal cell carcinoma in adults : expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol 31 : 1149-1160, 2007
PubMed
3) Tickoo SK, dePeralta-Venturina MN, Harik LR et al : Spectrum of epithelial neoplasms in end-stage renal disease : an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 30 : 141-153, 2006
PubMed
4) Gobbo S, Eble JN, Grignon DJ et al : Clear cell papillary renal cell carcinoma : a distinct histopathologic and molecular genetic entity. Am J Surg Pathol 32 : 1239-1245, 2008
PubMed
5) Srigley JR, Delahunt B : Uncommon and recently described renal carcinomas. Mod Pathol 22 (Suppl 2) : S2-S23, 2009
 
6) Tretiakova MS, Sahoo S, Takahashi M et al : Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma. Am J Surg Pathol 28 : 69-76, 2004
PubMed
7) Pan CC, Chen PC, Ho DM : The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma : an immunohistochemical analysis of 328 cases. Histopathology 45 : 452-459, 2004
PubMed
8) Argani P, Lal P, Hutchinson B et al : Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions : a sensitive and specific immunohistochemical assay. Am J Surg Pathol 27 : 750-761, 2003
PubMed
9) Avery AK, Beckstead J, Renshaw AA et al : Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol 24 : 203-210, 2000
PubMed
10) Tickoo SK, Reuter VE : Collecting duct carcinoma. in McKenney JK, Tickoo SK, Paner GP et al (eds) : "Diagnostic Pathology Genitourinary", Amirsys, Canada, 2010, pp64-69
 
P.200 掲載の参考文献
1) Murphy WM, Grignon DJ, Perlman EJ (eds) : AFIP Atlas of Tumor Pathology, Fourth series, Fascicle 1 : Tumors of the Kidney, Bladder, and Related Urinary Structures, ARP, Washington, DC, 2004, pp101-216
 
2) Chen Y-B, Tickoo SK : Spectrum of preneoplastic and neoplastic cystic lesions of the kidney. Arch Pathol Lab Med 136 : 400-409, 2012
PubMed
3) Turbiner J, Amin MB, Humphrey PA et al : Cystic nephroma and mixed epithelial and stromal tumor of kidney : a detailed clinicopathologic analysis of 34 cases and proposal for renal epithelial and stromal tumor (REST) as a unifying term. Am J Surg Pathol 31 : 489-500, 2007
PubMed
4) Zhou M, Kort E, Hoekstra P et al : Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney are the same disease entity : molecular and histologic evidence. Am J Surg Pathol 33 : 72-80, 2009
PubMed
5) Williamson SR, Halat S, Eble JN et al : Multilocular cystic renal cell carcinoma. Similarities and differences in immunoprofile compared with clear cell renal cell carcinoma. Am J Surg Pathol 36 : 1425-1433, 2012
PubMed
6) Suzigan S, Lopez-Beltran A, Montironi R et al : Multilocular cystic renal cell carcinoma : a report of 45 cases of a kidney tumor of low malignant potential. Am J Clin Pathol 125 : 217-222, 2006
PubMed
7) Gobbo S, Eble JN, Grignon DJ et al : Clear cell papillary renal cell carcinoma : a distinct histopathologic and molecular genetic entity. Am J Surg Pathol 32 : 1239-1245, 2008
PubMed
8) Aydin H, Chen L, Chen L et al : Clear cell tubulopapillary renal cell carcinoma : a study of 36 distinctive low-grade epithelial tumors of the kidney. Am J Surg Pathol 34 : 1608-1621, 2010
 
9) Rohan SM, Xiao Y, Liang Y et al : Clear-cell papillary renal cell carcinoma : molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. Mod Pathol 24 : 1207-1220, 2011
 
10) Camparo P, Vasiliu V, Molinie V et al : Renal translocation carcinomas : clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature. Am J Surg Pathol 35 : 656-670, 2008
 
P.204 掲載の参考文献
1) Ljungberg B, Cowan NC, Hanbury DC et al : European Association of Urology Guideline Group. EAU guidelines on renal cell carcinoma : the 2010 update. Eur Urol 3 : 398-406, 2010
 
2) 長嶋洋治, 青木一郎, 稲山嘉明他 : 乳頭状腎細胞癌と集合管癌. 病理と臨床 28 : 1048-1052, 2010
Medical*Online
3) Carvalho JC, Thomas DG, McHugh JB et al : p63, CK7, PAX8 and INI-1 : an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system. Histopathology 60 : 597-608, 2012
PubMed
4) Albadine R, Schultz L, Illei P et al : PAX8 (+) /p63 (-) immunostaining pattern in renal collecting duct carcinoma (CDC) : a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract. Am J Surg Pathol 34 : 965-969, 2010
PubMed
5) 松嵜理 : 浸潤性増殖. 病理形態学キーワード, 病理と臨床 28 (臨増) : 204-205, 2010
 
6) 都築豊徳, 前田永子, 岩崎博文 : 腎腫瘍針生検の病理. 病理と臨床 30 : 973-977, 2012
Medical*Online
7) Gunia S, Erbersdobler A, Koch S et al : Protein gene product 9.5 is diagnostically helpful in delineating high-grade renal cell cancer involving the renal medullary/sinus region from invasive urothelial cell carcinoma of the renal pelvis. Hum Pathol 44 : 712-717, 2013
PubMed
8) Akhtar M, Tulbah A, Kardar AH et al : Sarcomatoid renal cell carcinoma : the chromophobe connection. Am J Surg Pathol 21 : 1188-1195, 1997
PubMed
9) Ozcan A, Zhai Q, Javed R et al : PAX-2 is a helpful marker for diagnosing metastatic renal cell carcinoma. Arch Pathol Lab Med 134 : 1121-1129, 2010
PubMed
10) Delahunt B, Eble JN : Papillary renal cell carcinoma : a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 10 : 537-544, 1997
PubMed
11) Shen SS, Truong LD, Scarpelli M et al : Role of immunohistochemistry in diagnosing renal neoplasms : when is it really useful? Arch Pathol Lab Med 136 : 410-417, 2012
PubMed
12) Paner GP, Srigley JR, Radhakrishnan A et al : Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney : significant immunophenotypic overlap warrants diagnostic caution. Am J Surg Pathol 30 : 13-19, 2006
PubMed

第4部 臨床との連携

P.215 掲載の参考文献
1) 国立がん研究センターがん対策情報センターがん情報サービス http://ganjoho.jp/public/statistics/backnumber/
 
2) Marumo K, Satomi Y, Miyao N et al : The prevalence of renal cell carcinoma : a nation-wide survey in Japan in 1997. Int J Urol 8 : 359-365, 2001
PubMed
3) Marumo K, Kanayama H, Miyao N et al : Prevalence of renal cell carcinoma : a nation-wide survey in Japan, 2002. Int J Urol 14 : 479-482, 2007
PubMed
4) Washio M, Mori M, Sakauchi F et al : Risk factors for kidney cancer in a Japanese population : findings from the JACC Study. J Epidemiol 15 (Suppl 2) : S203-S211, 2005
 
5) Hunt JD, van der Hel OL, McMillan GP et al : Renal cell carcinoma in relation to cigarette smoking : meta-analysis of 24 studies. Int J Cancer 114 : 101-108, 2005
PubMed
6) Hsu CC, Chow WH, Boffetta P et al : Dietary risk factors for kidney cancer in Eastern and Central Europe. Am J Epdemiol 166 : 62-70, 2007
 
7) Mohr SB, Gorham ED, Garland CF et al : Are low ultraviolet B and high animal protein intake associated with risk of renal cancer? Int J Cancer 119 : 2705-2709, 2006
PubMed
8) Hiasa Y, Ito N : Experimental induction of renal tumors. Crit Rev Toxicol 17 : 279-343, 1987
PubMed
9) Rashidkhani B, Lindblad P, Wolk A : Fruits, vegetables and risk of renal cell carcinoma : a prospective study of Swedish women. Int J Cancer 113 : 451-455, 2005
PubMed
10) Lee JE, Spiegelman D, Hunter DJ et al : Fat, protein, and meat consumption and renal cell cancer risk : a pooled analysis of 13 prospective studies. J Natl Cancer Inst 100 : 1695-1706, 2008
 
11) 日本泌尿器科学会 (編) : 腎癌診療ガイドライン 2011年版, 金原出版, 2011
 
12) Aso Y, Homma Y : A survey on incidental adrenal tumors in Japan. J Urol 147 : 1478-1481, 1992
PubMed
13) Mihara S, Kuroda K, Yoshioka R et al : Early detection of renal cell carcinoma by ultrasonographic screening-based on the results of 13 years screening in Japan. Ultrasound Med Biol 25 : 1033-1039, 1999
PubMed
14) Hilton S : Imaging of renal cell carcinoma. Semin Oncol 27 : 150-159, 2000
PubMed
15) Kouba E, Smith A, McRackan D et al : Watchful waiting for solid renal masses : insight into the natural history and results of delayed intervention. J Urol 177 : 466-470, 2007
PubMed
16) Simopoulos E, McKim S, Raynor M et al : Long term follow-up of patients initially managed with active surveillance for solid renal masses. AUA 2010 Meeting Program
 
17) McKiernan JM : The evolution of small renal masses and the case for active surveillance. AUA Course Handout, 21PG, 2010
 
18) Volpe A, Mattar K, Finelli A et al : Contemporary results of percutaneous biopsy of 100 small renal masses : a single center experience. J Urol 180 : 2333-2337, 2008
PubMed
19) Leveridge M, Shiff D, Chung H et al : Percutaneous biopsy of small renal masses : outcomes of initial and repeat biopsy. AUA 2010 Meeting Program
 
20) 大園誠一郎, 杉山貴之, 野畑俊介 : 腎癌予防研究のレビュー. 日本腎泌尿器疾患予防医学研究会誌 18 : 28-31 ,2010
 
21) 大園誠一郎, 高山達也, 甲斐文丈他 : Incidentalomaのわが国の実態. 第34回尿路悪性腫瘍研究会記録, 6-11, 2008
 
P.223 掲載の参考文献
1) Israel GM, Bosniak MA : An update of the Bosniak renal cyst classification system. Urology 66 : 484-488, 2005
PubMed
2) Frank I, Blute ML, Cheville JC et al : Solid renal tumors : an analysis of pathological features related to tumor size. J Urol 170 : 2217-2220, 2003
 
3) Jinzaki M, Tanimoto A, Mukai M et al : Double-phase helical CT of small renal parenchymal neoplasms : correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr 24 : 835-842, 2000
PubMed
4) Jinzaki M, Tanimoto A, Narimatsu Y et al : Angiomyolipoma : imaging findings in lesions with minimal fat. Radiology 205 : 497-502, 1997
PubMed
5) Silverman SG, Mortele KJ, Tuncali K et al : Hyperattenuating renal masses : etiologies, pathogenesis, and imaging evaluation. Radiographics 27 : 1131-1143, 2007
PubMed
6) Silverman SG, Israel GM, Herts BR et al : Management of the incidental renal mass. Radiology 249 : 16-31, 2008
PubMed
7) Bosniak MA : The small (less than or equal to 3.0cm) renal parenchymal tumor : detection, diagnosis, and controversies. Radiology 179 : 307-317, 1991
 
8) Jinzaki M, McTavish JD, Zou KH et al : Evaluation of small (< /=3cm) renal masses with MDCT : benefits of thin overlapping reconstructions. AJR Am J Roentgenol 183 : 223-228, 2004
 
9) Hindman NM, Bosniak MA, Rosenkrantz AB et al : Multilocular cystic renal cell carcinoma : comparison of imaging and pathologic findings. AJR Am J Roentgenol 198 : W20-W26, 2012
PubMed
10) Shinmoto H, Yuasa Y, Tanimoto A et al : Small renal cell carcinoma : MRI with pathologic correlation. J Magn Reson Imaging 8 : 690-694, 1998
PubMed
11) Yamada T, Endo M, Tsuboi M et al : Differentiation of pathologic subtypes of papillary renal cell carcinoma on CT. AJR Am J Roentgenol 191 : 1559-1563, 2008
 
12) Fukuya T, Honda H, Goto K et al : Computed tomographic findings of Bellini duct carcinoma of the kidney. J Comput Assist Tomogr 20 : 399-403, 1996
PubMed
13) Kato H, Kanematsu M, Yokoi S et al : Renal cell carcinoma associated with Xp11. 2 translocation/TFE3 gene fusion : radiological findings mimicking papillary subtype. J Magn Reson Imaging 33 : 217-220, 2011
PubMed
14) Sahni VA, Hirsch MS, Sadow CA et al : Mucinous tubular and spindle cell carcinoma of the kidney : imaging features. Cancer Imaging 12 : 66-71, 2012
PubMed
15) Davidson AJ, Hayes WS, Hartman DS et al : Renal oncocytoma and carcinoma : failure of differentiation with CT. Radiology 186 : 693-696, 1993
PubMed
16) Choyke PL, Glenn GM, Walther MM et al : Hereditary renal cancers. Radiology 226 : 33-46, 2003
PubMed
17) Akita H, Jinzaki M, Akita A et al : Renal cell carcinoma in patients with acquired cystic disease of the kidney : Assessment using a combination of T2-weighted, diffusionweighted, and chemical-shift MRI without the use of contrast material. J Magn Reson Imaging 2013 (in press)
 
18) Moulopoulos A, DuBrow R, David C et al : Primary renal carcinoid : computed tomography, ultrasound, and angiographic findings. J Comput Assist Tomogr 15 : 323-325, 1991
PubMed
19) Tanabe A, Naruse M, Ogawa T : Dynamic computer tomography is useful in the differential diagnosis of juxtaglomerular cell tumor and renal cell carcinoma. Hypertens Res 24 : 331-336, 2001
PubMed
20) Bosniak MA : Angiomyolipoma (hamartoma) of the kidney : a preoperative diagnosis is possible in virtually every case. Urol Radiol 3 : 135-142, 1981
PubMed
21) Bosniak MA, Megibow AJ, Hulnick DH et al : CT diagnosis of renal angiomyolipoma : the importance of detecting small amounts of fat. Am J Roentogenol 15 : 497-501, 1988
 
22) Jinzaki M, Tanimoto A, Narimatsu Y et al : Angiomyolipoma : imaging findings in lesions with minimal fat. Radiology 205 : 497-502, 1997
PubMed
23) Park HK, Zhang S, Wong MK et al : Clinical presentation of epithelioid angiomyolipoma. Int J Urol 14 : 21-25, 2007
PubMed
24) Tsukada J, Jinzaki M, Yao M et al : Epithelioid angiomyolipoma of the kidney : Radiological imaging. Int J Urol 2013 (in press)
 
25) Mikami S, Oya M, Mukai M : Angiomyolipoma with epithelial cysts of the kidney in a man. Pathol Int 58 : 664-667, 2008
 
26) Rosenkrantz AB, Hecht EM, Taneja SS et al : Angiomyolipoma with epithelial cysts : mimic of renal cell carcinoma. Clin Imaging 34 : 65-68, 2010
PubMed
27) Park HS, Kim SH, Kim SH et al : Benign mixed epithelial and stromal tumor of the kidney : imaging findings. J Comput Assist Tomogr 29 : 786-789, 2005
PubMed
28) Tsurukawa H, Iuchi H, Osanai H et al : Renomedullary interstitial cell tumor : a case report. Nihon Hinyokika Gakkai Zasshi 91 : 37-40, 2000
PubMed
P.231 掲載の参考文献
1) Mitchell RE, Gilbert SM, Murphy AM et al : Partial nephrectomy and radical nephrectomy offer similar cancer outcomes in renal cortical tumors 4cm or larger. Urology 67 : 260-264, 2006
PubMed
2) Hollingsworth JM, Miller DC, Dunn RL et al : Surgical management of low-stage renal cell carcinoma : Technology dose not supersede biology. Urology 67 : 1175-1180, 2006
 
3) Marszalek M, Carini M, Chlosta P et al : Positive surgical margins after nephron-sparing surgery. Eur Urol 61 : 757-763, 2012
PubMed
4) Stern JM, Gupta A, Raman JD et al : Radiofrequency ablation of small renal cortical tumours in healthy adults : renal function preservation and intermediate oncological outcome. BJU Int 104 : 786-789, 2009
PubMed
5) Berger A, Kamoi K, Gill IS et al : Cryoablation for renal tumors : current status. Curr Opin Urol 19 : 138-142, 2009
 
6) Jewett MA, Mattar K, Basiuk J et al : Active surveillance of small renal masses : progression patterns of early stage kidney cancer. Eur Urol 60 : 39-44, 2011
PubMed
7) Messing EM, Manola J, Wilding G et al : Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma : An Eastern Cooperative Oncology Group/Intergroup Trial. J Clin Oncol 21 : 1214-1222, 2003
 
8) Latif F, Tory K, Gnarra J et al : Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260 : 1317-1320, 1993
PubMed
9) Escudier B, Eisen T, Stadler WM et al : Sorafenib for treatment of renal cell carcinoma : Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial. J Clin Oncol 27 : 3312-3318, 2009
 
10) Motzer RJ, Hutson TE, Tomczak P et al : Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356 : 115-124, 2007
PubMed
11) Rini BI, Escudier B, Tomczak P et al : Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS) : a randomised phase 3 trial. Lancet 378 : 1931-1939, 2011
 
12) Sternberg CN, Davis ID, Mardiak J et al : Pazopanib in locally advanced or metastatic renal cell carcinoma : results of a randomized phase III trial. J Clin Oncol 28 : 1061-1068, 2010
PubMed
13) Escudier B, Porta C, Bono P et al : Patient preference between pazopanib (Paz) and sunitinib (San) : Results of a randomized double-blind, placebo-controlled, cross-over study in patients with metastatic renal cell carcinoma (mRCC) -PISCES study, NCT 01064310. J Clin Oncol 30 (suppl ; abstr 4502), 2012
 
14) Escudier B, Pluzanska A, Koralewski P et al : Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma : a randomised, double-blind phase III trial. Lancet 370 : 2103-2111, 2007
PubMed
15) Horiguchi A, Oya M, Uchida A et al : Elevated Akt activation and its impact on clinicopathological features of renal cell carcinoma. J Urol 169 : 710-713, 2003
PubMed
16) Hara S, Oya M, Mizuno R et al : Akt activation in renal cell carcinoma : contribution of a decreased PTEN expression and the induction of apoptosis by an Akt inhibitor. Ann Oncol 16 : 928-933, 2005
PubMed
17) Motzer RJ, Escudier B, Oudard S et al : RECORD-1 Study Group : Efficacy of everolimus in advanced renal cell carcinoma : a double-blind, randomised, placebo-controlled phase III trial. Lancet 372 : 449-456, 2008
 
18) Hudes G, Carducci M, Tomczak P et al : Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 356 : 2271-2281, 2007
PubMed
P.238 掲載の参考文献
1) von Hippel E : Vorstellung eines Patienten mit einer sehr ungewohnlichen Netzhaut. Ber Deutsch Ophthal Ges 24 : 269, 1895
 
2) von Hippel E : Uber eine sehr seltene erkrankung der Netzhaut. Klinische Beobachtungen. Graefes Arch Ophthalmol 59 : 83-106, 1904
 
3) Lindau A : Studien uber Kleinhirncysten : Bau, Pathogenese und Beziehungn zur Angiomatosis retinae. Acta Pathol Microbiol Scand 1 (Suppl) : 1-128, 1926
 
4) Lindau A : Zur Frage der Angiomatosis Retinae und Ihrer Hirncomplikation. Acta Ophthal 4 : 193-226, 1927
 
5) Melmon KL, Rosen SW : Lindau's disease : review of the literature and study of a large kindred. Am J Med 36 : 595-617, 1964
PubMed
6) Lamiell JM, Salazar FG, Hsia YE : Von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine (Baltimore) 68 : 1-29, 1989
PubMed
7) Seizinger BR, Rouleau GA, Ozelius LJ et al : Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 332 : 268-269, 1988
 
8) Latif F, Tory K, Gnarra J et al : Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260 : 1317-1320, 1993
PubMed
9) Renbaum P, Duh FM, Latif F et al : Isolation and characterization of the full-length 3' untranslated region of the human von Hippel-Lindau tumor suppressor gene. Hum Genet 98 : 666-671, 1996
 
10) Iliopoulos O, Kibel A, Gray S et al : Tumour suppression by the human von Hippel-Lindau gene product. Nat Med 1 : 822-826, 1995
 
11) Schoenfeld A, Davidowitz EJ, Burk RD : A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor. Proc Natl Acad Sci USA 95 : 8817-8822, 1998
 
12) Kamura T, Koepp DM, Conrad MN et al : Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science 284 : 657-661, 1999
PubMed
13) Maxwell PH, Wiesener MS, Chang GW et al : The tumour suppressor protein VHL targets hypoxia inducible factors for oxygen-dependent proteolysis. Nature 399 : 271-275, 1999
PubMed
14) Stebbins CE, Kaelin WG Jr, Pavletich NP : Structure of the VHL-ElonginC-ElonginB complex : implications for VHL tumor suppressor function. Science 284 : 455-461, 1999
PubMed
15) Ivan M, Kondo K, Yang H et al : HIFalpha targeted for VHL-mediated destruction by proline hydroxylation : implications for O2 sensing. Science 292 : 464-468, 2001
PubMed
16) Jaakkola P, Mole DR, Tian YM et al : Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292 : 468-472, 2001
 
17) Pouyssegur J, Dayan F, Mazure NM : Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441 : 437-443, 2006
PubMed
18) Kelly BD, Hackett SF, Hirota K et al : Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 93 : 1074-1081, 2003
PubMed
19) Ceradini DJ, Kulkarni AR, Callaghan MJ et al : Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10 : 858-864, 2004
PubMed
20) Manalo DJ, Rowan A, Lavoie T et al : Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105 : 659-669, 2005
PubMed
21) Frew IJ, Krek W : pVHL : a multipurpose adaptor protein. Sci Signal 1 : pe30, 2008
PubMed
22) Kaelin WG Jr : The von Hippel-Lindau tumour suppressor protein : O2 sensing and cancer. Nat Rev Cancer 8 : 865-873, 2008
PubMed
23) Schmidt L, Duh FM, Chen F et al : Germline and somatic mutations in the tyrosine kinase domain of the MET protooncogene in papillary renal carcinomas. Nat Genet 16 : 68-73, 1997
PubMed
24) Isaacs JS, Jung YJ, Mole DR et al : HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer : novel role of fumarate in regulation of HIF stability. Cancer Cell 8 : 143-153, 2005
PubMed
25) Birt AR, Hogg GR, Dube WJ : Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol 113 : 1674-1677, 1977
PubMed
26) Schmidt LS, Warren MB, Nickerson ML et al : Birt-Hogg-Dube syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2. Am J Hum Genet 69 : 876-882, 2001
PubMed
27) Takahashi A, Hayashi T, Yoshida O et al : Renal cell carcinoma in the Birt-Hogg-Dube syndrome : report of a case. Hinyokika Kiyo 47 : 719-721, 2001
PubMed
28) Vocke CD, Yang Y, Pavlovich CP et al : High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dube-associated renal tumors. J Natl Cancer Inst 97 : 931-935, 2005
PubMed
29) Baba M, Hong SB, Sharma N et al : Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Proc Natl Acad Sci USA 103 : 15552-15557, 2006
PubMed
30) Varela I, Tarpey P, Raine K et al : Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 469 : 539-542, 2011
PubMed
31) Gerlinger M, Rowan AJ, Horswell S et al : Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366 : 883-892, 2012
PubMed
32) 医療における遺伝学的検査・診断に関するガイドライン, 日本医学会, 2011 http://jams.med.or.jp/guideline/genetics-diagnosis.html
 
33) 遺伝学的検査に関するガイドライン, 遺伝医学関連10学会, 2003 http://www.kyoto-u.ac.jp/ja/research/ethic/genome/documents/gaidorain.pdf
 
34) ヒトゲノム・遺伝子解析研究に関する倫理指針 http://www.mhlw.go.jp/general/seido/kousei/i-kenkyu/genome/0504sisin.html
 
P.245 掲載の参考文献
1) 日本泌尿器科学会, 日本病理学会, 日本医学放射線学会 (編) : 泌尿器科・病理・放射線科 腎癌取扱い規約, 第4版, 金原出版, 2011, pp56-94
 
2) Eble JN, Togashi K, Pisari P : Renal cell carcinoma. in Eble JN, Sauter G, Epstein JI et al (eds) : "WHO Classification of Tumours. Pathology & Genetics. Tumours of the Urinary System and Male Genital Organs", IARC Press, Lyon, 2004, pp12-22
 
3) Sobin LH, Gospodarowics MK, Wittekind CH : TNM Classification of Malignant Tumours, 7th ed, Wiley-Blackwell Inc, New York, 2009
 
4) Edge SB, Byrd DR, Compton CC et al (eds) : AJCC Cancer Staging Manual, 7th ed, Springer-Verlag, Munich, 2010
 
5) Fuhrman SA, Lasky LC, Limas C : Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6 : 655-663, 1982
PubMed
6) Hashimoto K, Sasajima Y, Ando M et al : Immunohistochemical profile for unknown primary adenocarcinoma. PLoS One 7 : e31181, 2012
PubMed
7) Srigley JR, Delahunt B : Uncommon and recently described renal carcinomas. Mod Pathol 22 : S2-S23, 2009
PubMed
8) Nagashima Y, Kuroda N, Yao M : Transition of organizational category on renal cancer. Jpn J Clin Oncol 43 : 233-242, 2013
PubMed

書評

最近チェックした商品履歴

Loading...